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Abstract 
Context: Clinical governance describes a systematic approach to ensuring the quality and 
safety of healthcare which has become accepted as one of the foundations of effective 
healthcare. This project describes the implementation of a clinical governance system in a 
private healthcare setting over a nine month period, in which lack of clinical governance and 
oversight had been identified as a significant risk. 
Aim: The aim of the project was to design and implement an effective, sustainable clinical 
governance system to ensure the safety and quality of care delivered in a private health 
screening service. 
Methods: The key principles and components of clinical governance, and evidence guiding 
effective implementation, were established through review of the literature. The HSE change 
model was used as the organisational development framework for the change process, 
including strategic analysis, stakeholder management, communication, planning and 
implementation.  
Evaluation: The project was evaluated against seven objectives using service data, clinical 
audit and a stakeholder survey to measure project implementation and project outcomes. 
Outcome evaluation was limited by the timescale of the project.  
Results: 71% of the objectives were fully achieved and 29% partly achieved. A causal link 
was established between the implementation approach and process change, and between 
process change and improved outcomes. Before-after evaluation of service data combined 
with clinical audit confirmed that clinical governance structures and processes were 
implemented and working as intended. Stakeholders perceived the change as positively 
affecting service safety, and the system design was seen as being fit for purpose without 
imposing an excessive workload. The leadership and change management approach were 
seen as effective, and there was evidence supporting the sustainability of the system. 
Conclusions: Use of the HSE change model, with a combined top-down and bottom-up 
approach, in the context of a model of engaging leadership and the development of 
distributed leadership, provides an effective approach to clinical governance implementation 
and healthcare innovation. Culture was an important enabler, while resourcing and 
information technology support emerged as important barriers. 
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Chapter 1: Introduction 
The goal of this project was to design and implement a clinical governance system in a 
private healthcare service using an organisational development approach. A fundamental 
change in healthcare over the last twenty years has been the emergence of a structured 
approach to ensuring and managing the quality and safety of healthcare, which was 
described by Scally and Donaldson as ‘clinical governance’, and defined as: ‘a framework 
through which [organisations] are accountable for continuously improving the quality of their 
services and safeguarding high standards of care by creating an environment in which 
excellence in clinical care will flourish’(Scally & Donaldson, 1998). This paper will outline the 
context in which the project took place, review the evidence base supporting the rational for 
the project, describe how it was implemented and evaluated, and will attempt to draw 
conclusions in relation to the literature on clinical governance and healthcare change 
management.  
1.1 Organisational Context and Rationale for the Project 
The project took place between June 2014 and March 2015 in the wellness department of a 
large organisation. The department was established in 2011 to provide health assessments 
through two medical centres. A separate occupational health department traditionally 
provided limited wellness screening services to employees of corporate groups in the 
workplace. Demand for these services had been increasing, and in January 2013 
responsibility for the corporate screening service was transferred to the wellness department. 
This service had grown rapidly, however its processes had been developed for use on a small 
scale by occupational health nurses under the direct supervision of an occupational health 
physician. Following the transfer of responsibility the service continued to operate largely 
independently of the operational and clinical structures of the department. This combination of 
transfer of responsibility, poorly defined accountability and rapid expansion of the service 
resulted in a poorly controlled environment in which it was not clear that the ethical obligation 
to provide safe, high quality care was being met. The primary driver of the project was the 
concern of clinical management regarding possible risks to patient safety as a result of the 
absence of clinical oversight and lack of management of clinical risk within a rapidly growing 
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service. Secondary drivers included concern about the level of operational governance, and 
the discrepancy between the current state and best practice in managing healthcare services, 
and concern about potential customer dissatisfaction, litigation, and the human, reputational 
and financial implications of possible adverse events. 
Changes in the regulatory environment in Ireland have increased the focus on healthcare 
quality, driven by the development of national healthcare standards by the Health Information 
and Quality Authority (HIQA) and the move towards licencing of public healthcare facilities. 
Although private healthcare is not under any legal obligation to comply with these standards 
or to be licenced by HIQA, many private healthcare facilities have voluntarily sought 
accreditation with independent regulators such as Joint Commission International (JCI) and 
ISO. In 2012 the wellness department was accredited by JCI. The existence of a service 
within the wellness department which was not accredited posed a threat to retaining overall 
accreditation which would have a significant reputational impact for the organisation beyond 
the wellness department. This threat was a significant secondary driver for the project. 
Following the transfer of responsibility for the service a number of improvement initiatives had 
been undertaken. Clinical operating procedures were reviewed and revised to bring them into 
line with the international and national guidelines in use in the department, and in early 2014 
a review of the service was completed by the author. This identified persistent weaknesses in 
the delivery and governance of the service. Clinical responsibility for patient management was 
poorly defined, and there was no clinical oversight of the health assessment process. Data on 
service quality, safety and outcomes was not being gathered, and there was no structured 
evaluation of the safety or quality of the service being delivered. Management of consultation 
records was very basic, and records were difficult to retrieve. In May 2014 the implementation 
of robust clinical governance structures and processes was established at director level as a 
departmental priority. 
1.2 The Project Plan 
With a high level mandate for the project in place the scope of the project was outlined. The 
project needed to put in place fundamental structures and processes to support clinical 
governance within the employee wellness service and to address the specific clinical risks 
identified in the review. The system needed to ensure that patient care within the service met 
acceptable standards of clinical quality and safety, aligned with international best practice and 
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local accreditation standards, which could be evaluated to measure the effectiveness of the 
system design and its implementation. The project was designed around the vision of a 
clinical governance system which ensured a well-defined and risk-managed service, 
providing safe effective care, without large associated costs, which was positioned for 
growth, development and accreditation. For organisational reasons the clinical governance 
system for the service would operate in parallel with established clinical governance in the 
wellness department. This meant developing and implementing a parallel set of structures, 
processes and controls. Ethical approval for the project was granted by the RCSI Research 
Ethics Committee (Appendix 12). As consent was not sought from patients for participation in 
the project no patient related data was reported. Data provided by staff was gathered 
anonymously. All data was managed in compliance with the Data Protection Acts 1988 & 
2003 and with reference to guidance of the Data Protection Commissioner (2007).  
1.3 Aim and Objectives  
The aim of the project was to design and implement a system of clinical governance for 
employee wellness programs provided in a workplace setting by the organisation through the 
wellness department. The specific objectives are listed in table 1. 
Table 1. Objectives of the project: 
1. To design and gain stakeholder agreement to an overarching 
governance document giving a formal definition of the clinical 
governance system, audited against the standard of the HSE Clinical 
Governance Matrix, by the end of December 2014.  
2. To design and implement a process for reporting and management of 
incidents and complaints by the end of December 2014. 
3. To design and implement a process for gathering patient satisfaction 
data by the end of December 2014, to obtain patient feedback from at 
least 5% of service users by the end of March 2015. 
4. To establish a project steering group to provide integrated clinical and 
operational leadership for clinical governance implementation, and 
management of safety and quality issues and ongoing quality 
improvement, by the end of October 2014 
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5. To design and implement a set of clinical oversight structures and 
processes, defined by clinical standard operating procedures, by the 
end of December 2014. 
6. To design and implement a system of clinical audit against the standard 
of evidence based standard operating procedures which will report 
results by the end of March 2015. 
7. To evaluate the success of the project against the objectives 1-6 
through a structured evaluation of implementation approach, user 
acceptance, process output and project outcomes by the end of April 
2015.  
 
1.4 Role of the student 
The role of the student in the project was to act as the principle change agent. To create a 
vision, produce the initial design, and to build commitment to the vision. It involved leading 
implementation of the change and coordinating the development of the project among the 
internal and external stakeholders while contributing a clinical perspective and organisational 
knowledge. It also involved a very hands on approach to policy and process design, 
dissemination and training and to evaluation of the results of the project. 
 
1.5 Development of the Project 
The next chapter reviews aspects of clinical governance literature in order to understand the 
principles of clinical governance and current best practice. This review was used to guide the 
design and implementation of the project by identifying themes and approaches that have 
been shown to contribute to successful implementation. The project aims to incorporate the 
principles of clinical governance into everyday practice, and to give them a tangible form 
through the implementation of best practice structures, processes and practices. Chapter 
three describes the organisational development approach taken to implementing the 
proposed system, including the change model used, the strategic context, the approach taken 
to implementing the change and the challenges encountered. It describes how the literature 
themes were applied to implementation of the project, and how the planned approach was 
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modified as the project developed. Experience of implementing clinical governance across a 
wide range of healthcare environments has shown that it can result in a ‘paper exercise’ 
which does not result in meaningful changes in practice or outcome (Braithwaite & Coiera, 
2010; Scott et al. 2008). Robust measures are required to confirm that the change has taken 
place and that it has had the desired effect (Ovreveit, 2002). Chapter four describes the 
evaluation of the change project, the evaluation framework used, and presents the results of 
that evaluation. Chapter five discusses the impact of the project in relation to its original 
objectives. It compares the experience of the project with research evidence to extract 
learnings and future guidance relating to implementing clinical governance and managing 
change in a healthcare setting, and to place this learning in the context of current knowledge 
about healthcare change management. 
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Chapter 2: Literature Review 
2.1 Introduction 
The purpose of the project was to design, implement and evaluate a system of clinical 
governance for a specific healthcare service. In order to understand the requirements for such 
a system a literature review was conducted with two objectives: To understand the evolution, 
key concepts, and current consensus on best practice in clinical governance, and to review 
the literature on effective implementation of clinical governance structures and systems.  
The first objective focuses on a set of publications which are almost universally referenced in 
reviews of clinical governance, and identifies the principles and recommendations that should 
define a clinical governance system. The second part reviews the literature on the 
implementation of clinical governance to identify themes and success factors which could 
guide the project. The search was initially focused on journal publications within the last five 
years, using the search terms ‘clinical governance’, ‘implementation’ and ‘organisational 
innovation’. These terms were searched for in Emerald, Health Business Elite, PubMed and 
cross checked against Google Scholar. The search was then widened and a snowball 
approach was taken to identifying further relevant sources.  Much of the published literature 
on implementation and evaluation is contained in the ‘grey literature’, and websites from the 
NHS, HSE (Lenus) and related healthcare organisations yielded important publications. 27 
papers were selected for review based on relevance to the topic, and four themes relating to 
effective implementation of clinical governance emerged, which are discussed below. 
 
2.2 Principles and Key Components of Clinical Governance 
Governance is defined by the oxford Concise Dictionary as ’The act or manner of governing’ 
(Oxford Press, 1995). In a corporate setting the definition has been extended to include 
accountability, decision making processes, and controls (Cadbury Report, 1992). The idea of 
processes and controls is implicit in the definition of an organisation (Robbins & Judge, 2013), 
however the  idea of structured governance in a healthcare setting is a surprisingly recent 
development, first recommended by the WHO in 1985 (WHO, 1985). The primary drivers for 
the development of governance systems in healthcare were public and political pressure 
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resulting from a series of high profile failures of healthcare safety. In America the Institute of 
Medicine estimated that between 44,000 and 98,000 deaths per year in America were caused 
by medical errors (IOM, 1999), and examined the root causes of these failures and suggested 
approaches to remedying them (IOM, 2001). It defined what a high quality medical system 
should deliver: safe, effective, patient-centred, timely, efficient and equitable healthcare (IOM, 
2001). These criteria have been almost universally accepted, and are visible in healthcare 
standards across the world (DoH, 2009; HIQA, 2012; JCI, 2015).  
The Bristol Inquiry at the Bristol Royal Infirmary identified serious deficiencies in how 
healthcare was managed and delivered, resulting in public horror and political pressure for 
change (Bristol Inquiry, 2001). The Department of Health white paper ‘The New NHS’ (DoH, 
1997) first used the term ‘clinical governance’ to describe an approach to quality assurance 
and improvement in healthcare, while Scally and Donaldson (1998) defined clinical 
governance, and outlined how it could be applied in the context of the NHS. In Ireland the 
report of the Lourdes Hospital Inquiry revealed deficiencies similar to those reported in other 
health services (DoHC, 2006). McAuliffe (2014) identifies this and similar reports as the key 
driver to develop clinical governance in Ireland. The 2007 report ‘Building a culture of patient 
safety’ (DoHC, 2008) makes over 130 recommendations with regard to how health services in 
Ireland are structured, managed, delivered and monitored. In 2013 the findings of the Francis 
Inquiry into the standard of care provided by the Mid-Staffordshire Hospital Trust begged the 
question of how the lessons of the previous ten years could fail to have been learned, despite 
huge investment in formal clinical governance (Francis, 2013). The white paper ‘A promise to 
learn- a commitment to act’, identified lack of integrated clinical and corporate governance, 
combined with failure to implement clinical governance, as two key contributing factors, and 
charted a path to address these (NHS, 2013). 
From these reports and strategy documents the key principles underpinning a valid and 
robust system of clinical governance were extracted (Appendix 1). Some are consistently 
identified as central to ensuring healthcare quality, such as a positive culture, leadership, 
evidence based medicine and patient centred care. The Institute of Medicine identified 
processes such as continuity of care, communication and teamwork (IOM, 2001), while the 
themes of accountability and responsibility, learning organisations, minimum healthcare 
standards, a systems approach to safety, clinical audit and competence assurance recur 
consistently (Bristol Inquiry, 2001; DoH, 1997, 2009; Francis, 2013; HSE, 2008; NHS, 2013). 
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Systems-based approaches to improving the quality and safety of care include incident 
reporting, analysis and prevention (IOM, 2001; NHS, 2004), use of evidence based medicine 
through the implementation of best practice guidelines (DoH 1997, 2000; Scally & Donaldson, 
1998), and clinical audit as a tool to support evidence based care (Benjamin, 2008; Copeland, 
2005). Systematic collection and analysis of patient experience was established as a vital 
failsafe (NHS, 2013) and a valid quality measure in itself (HSE, 2013a). Effective complaint 
management can act as an early warning system (Beaupert et al., 2014), and a trigger for 
performance management (DoHC, 2008).  These components are now accepted as intrinsic 
to effective clinical governance systems.  
Development of recognised quality frameworks such as the NHS seven pillars of clinical 
governance (Nicholls et al., 2000), and more recently the Australian model (Robinson et al., 
2008) and the Health Service Executive (HSE) Clinical Governance Development Matrix 
(HSE, 2012), provide structure, legitimacy and direction  to clinical governance systems 
(Braithwaite & Coeira, 2010; HSE, 2012). Both of these later frameworks provide a clear 
outline of the governance structures, processes and outputs which comprise internationally 
recognised best practice. 
A further approach to structuring clinical governance involves the concept of healthcare 
accreditation to minimum safety and quality based standards. Despite questions about the 
effectiveness of standards and accreditation in improving healthcare quality (Braithwaite & 
Coeira, 2010; Chen et al., 2003; Greenfield et al., 2012; Paccioni et al., 2008, ), the concept 
of accreditation, or licencing, based on meeting defined standards have been embedded in 
legislation and regulatory processes in many jurisdictions including Ireland (DoH, 1997, 2008, 
2009; Health Act, 2007). The National Institute of Clinical Excellence was established to 
develop standards for the NHS, while in Ireland the Health Information and Quality Authority 
(HIQA) developed the National Standards for Better Safer Healthcare (HIQA, 2012), which 
became mandatory for all Irish public health services from 2013. 
2.3 Clinical Governance Implementation 
International consensus clearly supports an urgent need for structured and monitored quality 
assurance in healthcare. It is also widely recognised that that change in a healthcare setting 
faces a number of unique challenges (Gilmartin & D’Aunno, 2007; Shekelle et al., 2011). This 
section examines the themes identified as important predictors of success or failure in the 
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implementation of clinical governance. As Benjamin comments, it is ironic that clinical 
governance, founded on the principles of evidence based medicine, has produced little 
evidence of improved patient outcomes (Benjamin 2008). Braithwaite examines the outcomes 
of clinical governance implementation in Australia, and finds that while there have been 
important successes (Haynes et al., 2009; Pronovost et al., 2006), there is little systematic 
evidence that rates of adverse events have fallen significantly (Braithwaite & Coeira, 2010). 
Scott et al. (2008) draw similar conclusions. Research on the outcomes of clinical audit 
programs have found modest and often equivocal benefits (Benjamin, 2008; Jamvedt et al., 
2006), while Som questions the value of investing resources in reporting, analysing and 
managing low level incidents (Som, 2009). One of the stark findings of the Francis inquiry was 
that widespread acceptance of the principles of clinical governance, and the existence of 
clearly defined clinical governance frameworks, were not adequate to ensure the safety and 
quality of care (Francis, 2013; NHS, 2013), and described clinical governance in the Mid-
Staffordshire Hospital as ‘vestigial’, despite the financial and political commitment of the NHS. 
It underlined the crucial importance of effective implementation in order to achieve the 
required outcomes of clinical governance. The themes described below were identified by the 
literature review as important predictors of successful implementation.   
2.4 Literature Themes 
2.4.1 Culture 
A consistent finding from examinations of healthcare failures, and from investigations into 
improvement strategies, is that organisational culture can be a root cause of problems (Bristol 
Inquiry, 2001; DoHC, 2006; Francis, 2013), a barrier to change (DoHC, 2008; Karassavidou 
et al., 2011) and a facilitator of change (HSE, 2012; Institute of Medicine, 2001; Lipworth et 
al., 2013;  NHS, 2004; Scally and Donaldson, 1998). It also shapes the form in which clinical 
governance is implemented  (Greenfield et al., 2011) and is in turn shaped by that 
implementation (Paccioni et al., 2008; Röthlin, 2013). Culture was defined by Shine (1984) as 
‘the pattern of basic assumptions that a given group has invented, discovered or developed in 
learning to cope with the problems of external adaptation and internal integration, that have 
worked well enough to be considered valid, and therefore, to be taught to new members as 
the correct way to perceive, think and feel in relation to these problems’. Writing in 1998 
Scally and Donaldson identify the features of culture likely to support implementation of 
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clinical governance: open and participative, ideas and good practice are shared, education 
and research are valued, and blame is used exceptionally, but admit that ‘evidence on how to 
define a ‘good’ culture, and on the methods needed to promote one’ is lacking (Scally and 
Donaldson, 1998).  
A review of the literature by Scott et al. finds that the link between healthcare culture and 
performance is contingent, that a clear distinction between culture and performance is difficult 
to draw, and that further evidence is needed to support policies based on cultural 
transformation (Scott et al., 2003). Greenfield et al. (2010) and Karassivadou et al. (2011) 
advocate evaluation of organisational culture as part of implementation of clinical governance 
to facilitate understanding of potential barriers, and consider how local culture shapes the 
systems that emerge from implementation. The commission on patient safety and quality 
assurance (DoHC, 2008) and Robinson et al. (2008), stress the need to advocate for a 
positive culture, and identify leadership, accountability, education and a focus on ethical 
behaviour as the key factors in translating the principles of quality and safety into practice. 
Carroll and Quijada (2004) describe a gradual approach to ‘tilting’ a culture, by building on 
positive aspects, and suggest that, being by definition a ‘successful adaptation to conditions’ 
those conditions need to be carefully selected and modified. They also highlight the crucial 
role of leadership in effecting culture change. Research by Paccioni et al. (2008) offers 
evidence that implementation of clinical governance through an accreditation process can 
promote aspects of positive culture, though he also emphasised the potential for unintended 
consequences inherent in approaches to managing culture, while Parmelli et al. (2011) did 
not identify any consistently effective strategies to change culture.  Finally, professional 
subcultures (clinical and managerial) play an important role in the receptiveness to clinical 
governance implementation (Scott et al., 2003a, 2003b; Davies 2001).  
 
2.4.2 Leadership  
Effective leadership is a consistent theme in the literature of clinical governance 
implementation. Most reports on failures in clinical care identify lack of leadership as an 
ingredient of disaster, and include development of effective leadership as a key 
recommendation to ensure future quality (Bristol Inquiry, 2001; DoHC, 2006; Francis, 2013; 
Institute of Medicine, 1998).  Implementing change requires vision, direction and motive force 
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(Kings Fund, 2011). Greenfield et al. (2011) describe implementation of clinical governance 
as one of the ‘wicked problems’ of healthcare, being highly complex, deeply rooted in context 
and susceptible to multiple valid perspectives and conflicting interpretations. Such problems 
demand the full scope of leadership attributes (Grint & Holt, 2011; Rittel & Weber, 1973).  
Transformational leadership described by Bass (1999) has been most studied in relation to 
healthcare (Gilmartin & D’Aunno, 2007). The NHS positioned leadership development at the 
centre of clinical governance development (DoH, 2008; Donaldson, 2002; NHS, 2004; The 
Kings Fund, 2011). The Kings Fund reviewed the nature of leadership required to meet the 
challenges posed by quality improvement in healthcare, and defined leadership as ‘the art of 
motivating people to achieve a common goal’, and identified vision, strategy, communication, 
consensus-building and conflict management as key elements of effective leadership (The 
Kings Fund’ 2011). They stress the importance of employee engagement as a pivotal 
determinant of healthcare performance and outcomes, and describe the role of leadership in 
creating this engagement (The Kings Fund, 2012). McLeod and Clarke (2009) define 
engagement as ‘the business values the employee and the employee values the business’.  
West and Dawson suggest that the leadership approach conducive to engagement in health 
services includes allowing autonomy, enabling use of a wide range of skills, giving ownership 
of tasks and giving support and encouragement, and advise moving away from a ‘command 
and control’ model of leadership (West & Dawson, 2012). In this context Alimo-Metcalfe and 
Alban-Metcalfe (2008, 2012) have proposed the ‘engaging leadership’ model, which builds on 
previous work on transformational leadership (Alimo-Metcalfe & Alban-Metcalfe, 2001; Bass, 
1999; Xirasagar, 2008), where the leader inspires followers to act beyond self-interest. This 
overlaps with the model of authentic leadership described by Avolio et al. (2009) in 
encompassing concepts such as personal integrity. It proposes four clusters of behaviour 
(Appendix 2), which have been evaluated and validated in terms of the model’s effect on 
engagement and performance (Alimo-Metcalfe & Alban-Metcalfe, 2008, 2012). Grint and Holt 
(2011) suggest that leadership alone is not enough, but that responsible followership is 
equally important, and that a crucial function of a leader is to enable the development of 
responsible followers, who in turn provide devolved leadership though an organisation. 
Carroll & Quijada (2004) describe the role of leadership in changing culture, including acting as 
role models, taking risks, supporting and protecting others in taking risks, acting honestly and 
with integrity, sense-making and interpreting change by building on existing positive cultural 
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strengths. The Commission on Patient Safety and Quality Assurance (DoHC, 2008) 
emphasise the importance of leadership in creating a culture of patient safety. Clinician 
leadership is stressed across the literature on clinical governance implementation (DoH, 
2008; Francis, 2013; Harlos et al., 2012; Hastings et al., 2014; Ovreveit et al., 2012; OHM, 
2000, 2003; NHS, 2004; The Kings Fund, 2011, 2012, 2013). Among the reasons given are 
clinician’s high level of professional autonomy, direct influence on healthcare outcomes and 
resource utilisation, being seen as representing values of patient care, and as role models 
and representatives of organisational values (Bohmer, 2012).  
 
2.4.3 Change Approach 
Most writers stress the importance of senior management commitment (HSE 2008, 2012, 
2014; Ovreveit et al., 2012; McAuliff & van Varenbergh, 2006, and others), though Ovreveit 
finds that it is not an essential requirement for successful change (Ovreveit et al, 2012). 
Despite support at the highest political, management and professional level many programs 
have failed to deliver significantly improved patient outcomes, suggesting that a top down 
approach may not be adequate. Research by Greenfield et al. (2011) describes the 
enthusiasm of managers for frameworks and standardised systems, while Degeling et al. 
(2004) show that clinical staff strongly supported patient centred initiatives, but had 
reservations about formalised approaches. Som (2009) emphasises the risk of 
disempowerment and disengagement by clinicians as a result of imposed top-down clinical 
governance systems. Degeling et al. (2004) suggest that clinical governance implementation 
has taken the form of an accreditation process focused on abstract issues, rather than on the 
people with direct experience of the problems. In a review of research on accreditation, 
Paccioni et al. (2008) suggest that top down imposition of systems can be perceived by 
clinicians as a managerial attempt to limit professional autonomy.  
Hastings et al. (2014), Paccioni et al. (2008) and Ovreveit et al. (2012) identify participation at 
all levels and across clinical and operational boundaries as one of the predictors of success. 
Singh (2009) has proposed an implementation model for each component of clinical 
governance at multiple organisational levels, while Harlos et al. (2012) find evidence for a 
supportive training environment and ‘open exchange despite power differences’ as a key to 
knowledge translation in management research. Research by Kelleher and McAuliff (2012) 
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and Provonost et al. (2006) argues convincingly for combining a top-down approach (senior 
management commitment) with a bottom-up approach (team based implementation by front-
line clinicians) which grounds implementation in reality while avoiding negative perceptions of 
an imposed ‘system’, and has proven effective in a number of healthcare settings. Pluye et al. 
(2004) stress the need to build sustainability into programs through resourcing, incentives and 
communication networks, as an essential adjunct to implementation, which is supported by 
research by Greenhalgh et al. (2012). Ovreveit et al. (2012) find that detailed systematic 
planning from the outset, combined with an effective project team was one of the strongest 
predictors of successful implementation of healthcare innovations.  
 
2.4.4 Resources  
Ovreveit highlights the cost of clinical governance programs, which are directly or indirectly 
carried by the organisation in which the change is taking place, and the urgency of ensuring 
the correct approach to implementation, including allocation of adequate management time, 
and appropriate evaluation of the costs (Ovreveit, 2002). Esain et al. (2012) identify lack of 
time allocated by management for problem identification as a restraining force. The Office for 
Health Management identified lack of time and remuneration as one of the barriers to 
engaging clinicians in management (OHM, 2003). (Groene et al., 2010) found one of the 
primary barriers to implementing the Performance Assessment Tool for Improvement in 
Hospitals (PATH) was lack of human resources allocated to the project combined with 
competing priorities. Greenfield et al. (2011) describes the availability of appropriate staff 
resources as essential for effective implementation of quality improvement programs, while a 
study by Som in the NHS (2009a) highlights the active human resource management (HRM) 
needed to ensure the people, skills and training required to implement clinical governance are 
in place. Conversely research by Ovreveit et al. (2012) found that change projects can be 
successfully implemented within existing resources, while Dixon-Woods et al. (2012) suggest 
that this is often a necessity, and increases the likelihood of sustainable change. 
The Francis Inquiry identified deficient HRM as a root cause of poor quality care (Francis, 
2013). Lack of healthcare resourcing and staffing, combined with the dual objectives of 
achieving both quality and quantity, could be considered the elephant in the room of clinical 
governance. Research by Som (2009b) found a widely held belief across clinicians and 
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managers that quality and quantity cannot coexist, and that tension between quality and 
quantitative targets leads to quality taking second place (Som, 2009b). He concludes that 
clinical governance does not answer the dilemma for healthcare staff regarding quality versus 
quantity, but rather exacerbates it (Som 2009b). Significantly, Som (2009b) and Hastings et 
al. (2014) identified a dearth of research around the relationship of resourcing and staffing 
levels to quality of care, despite the recent impact of austerity on many health services, and 
evidence that inadequate resourcing is a root cause of healthcare failures (Francis, 2013).  
 
2.5 Conclusion 
The literature review established the principles of safe, high quality healthcare and the key 
components required for the design of a robust system of clinical governance, and identified 
frameworks to guide its design. International consensus that clinical governance constitutes 
an essential mechanism for ensuring delivery of safe effective healthcare underpins the 
rationale for the project. Effective implementation of healthcare improvement initiatives 
emerges as critical to effective clinical governance, and the evidence reviewed supported four 
key themes which contribute to the success or failure of clinical governance implementation. 
These themes, culture, leadership, change approach, and resources, were highly relevant to 
the project and guided the approach taken to preparation and implementation, while a fifth 
theme, healthcare evaluation is explored in chapter four.  
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Chapter 3: Methods and Methodology 
3.1 Introduction and change model 
“It must be considered that there is nothing more difﬁcult to carry out, nor more doubtful of 
success, nor more dangerous to handle, than to initiate a new order of things.” (Macchiavelli, 
1500’s), and considerable effort has been put into developing strategies and techniques to aid 
successful implementation of organisational change. Organisational development has been 
defined as ‘an effort, planned, organisation-wide, and managed from the top, to increase 
organisation effectiveness and health through planned interventions in the organisation’s 
‘processes’, using behavioral science knowledge’. (Beckhard, 1969). More simply it has been 
described as ‘a collection of change methods, using behavioural science, that try to improve 
organisational effectiveness’ (Robbins & Judge, 2012). Change models are the planning tools 
used to map and drive the change process. A range of change models have evolved, starting 
with Lewin’s field change model in the 1950’s (Lewin 1951), through the step change models 
of Kotter (1998) and Beer et al. (1990), and action learning models (Coghlan & Brannick, 
2010), to integrated organisational development models (HSE, 2008; Senior & Swailes, 
2010). As Young shows, the core steps or components of change can be distilled into nine 
elements which are remarkably consistent across all models (Young, 2009).  
The literature review identified evidence supporting both a top-down and a bottom-up 
approach to change as a predictor of successful implementation of clinical governance. The 
HSE change model (HSE, 2008) represents a holistic organisational development model, 
which pays particular attention to stakeholder involvement at all levels and is well suited to the 
combined change approach suggested by the literature review. It integrates aspects all the 
change models described above and encompasses Young’s nine themes (Young, 2009). It 
recognises the non-linear nature of organisational change, and suggests how to approach 
this. It is designed for use in the context of public health services, and the specific challenges 
of healthcare change. It encourages strategic and systems thinking, preparation, planning and 
collaboration. While there is no research evidence supporting its effectiveness in practice, it is 
built on a solid evidence base (McAuliff & van Varenbergh, 2006). It is detailed and pre-
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supposes prior knowledge of change management theory, however it is suitable for a large 
scale change such as this project, which is systemic in nature, and subject to modification for 
the setting of the project, it was selected as the most appropriate model for this change. This 
chapter describes the evolution of the change project following the structure of the HSE 
change model (Figure 1). 
Figure 1. HSE change model (HSE, 2008) 
 
 
3.2 Initiation 
3.2.1 Strategic analysis and organisational context 
The triggers for this change were the externally driven transfer of responsibility for the service 
to the wellness department, the rapid expansion of the service, and concerns about clinical 
safety and quality. The PESTLE analysis, as described by CIPD (www.cipd.co.uk/hr-
resources/factsheets/pestle-analysis.aspx, accessed September 2014), identified further 
external drivers, including a national focus on safety and quality, increasing regulatory 
scrutiny and public expectation, increasing business demands, a challenging economic 
environment and competitive pressures (Appendix 3a). A TOWS analysis (Weihrich, 1982) 
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was used to explore how these external pressures interacted with internal factors to identify 
appropriate strategic responses (Appendix 3b). Lewin describes the balance of driving and 
restraining forces as an important predictor of success for a change (Lewin, 1951). Lewin’s 
force field analysis was used to evaluate and prioritise these forces, and to design strategies 
to address them (Appendix 3c). 
Not creating a sense of urgency was identified by Kotter as a predictor of failure (Kotter, 
1995), and Dixon-Woods et al. stress the importance of convincing people that there is a 
problem as the starting point for successful change (Dixon-Woods et al., 2012).  Evaluation of 
the level of urgency and its implications are advised by the HSE change model, however they 
do not specifically address the issue of creating urgency. In this project different stakeholder 
assessments and perspectives resulted in widely different perceptions of the level of urgency. 
Aligning clinical and management perspectives, as described by Som (2009) and Harlos et al. 
(2012), and creating and maintaining a sense of urgency was identified at this stage as a key 
challenge for the project. 
Identification and management of stakeholders is a central theme of the change management 
literature (e.g. Bryson, 2004). Nutt and Backhoff (1992) define stakeholders as ‘all parties who 
will be affected by or will affect the organisations strategy’. Characterisation of stakeholders 
using a power-interest matrix (NHS 2008), combined with the Participation Planning Matrix 
(Bryson, 2004) provided a valuable guide to stakeholder interests (Appendix 3d). 
D’Herbemont’s stakeholder typology was used to evaluate relative commitment and potential 
resistance to the project (Figure 2, after d’Herbemont & Cesar, 1998). The analysis suggested 
low levels of antagonism and resistance, but also low levels of active support. Clinical staff 
were supportive, but unlikely to drive the project. Senior clinical management were very 
supportive but dis-engaged. Operational management were not convinced of the urgency for 
change, while clinical and nursing management were most actively supportive and also most 
directly involved. The analysis indicated that leadership for the project would need to come 
from clinical and nursing management. Leadership for the project would also need to be 
found within operational management to ensure an effective guiding coalition. Kotter & 
Slesinger (2008) suggest participation as the model best suited to promoting engagement in 
this setting, while Grint and Holt (2012) and The Kings Fund (2012) advise empowerment, 
ownership and support as the best way to promote leadership and responsible followership.  
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Figure 2. Stakeholder typology (after d’Herbemont & Cesar, 1998) 
 
Kotter and Schlesinger (2008) propose a framework to address resistance. Some resistance 
was expected due to changes in work practice among the nursing team, and from the medical 
team who previously had no involvement with the service. The expected basis was principally 
lack of clarity about the underlying risks driving the change. A combination of communication, 
facilitation and education, is the most effective approach to minimising such resistance and 
building durable commitment (Dixon-Woods et al., 2012; HSE, 2008; Kotter & Schlesinger, 
2008). Resistance was anticipated from operational management on the basis of a differing 
assessment of the cost benefit of the change. A combination of communication (of vision and 
drivers), alignment of objectives, and a collaborative approach to planning the change, was 
the approach most likely to undermine resistance and gain commitment (Kotter & 
Schlesinger, 2008). Finally a degree of resistance was anticipated from nursing management. 
Many of the new processes would directly involve them, and would inevitably carry resource 
costs. The legitimacy of these issues and their vital role as partners in the change indicated 
the need for a high degree of participation in the planning and implementation of the change.  
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The wellness department conforms to a model of a professional bureaucracy (Mintzberg, 
1981), and the importance and influence of the professionals in the ‘operating core’ 
suggested that a ’bottom up’ approach with senior management support, would be needed to 
secure clinical engagement and sustainability. The position of the department as a ‘division’ 
within a traditional bureaucracy meant that it was subject to conflicting demands and dispersal 
of resources. This impacted on the resources available for the change project, and there was 
an implicit assumption that the project needed to be effectively cost neutral. Otherwise there 
was a good alignment with organisational strategy, including a low tolerance for clinical risk, 
so that combined with senior management support, little organisational resistance was 
expected.  
Provonost et al. (2006) advise formal evaluation of organisational culture to guide change. 
Operational management of the service were highly business orientated, and the culture was 
un-hierarchical and task orientated, with a relatively formal approach to communication 
through meetings, and shared goals as a unifying force, and represented a generally positive 
and dynamic mercenary culture (after Goffee & Jones, 1996). Clinical staff formed a typical 
subculture, as described by Kearns (2005), with a strong patient focus. Results of previous 
departmental surveys indicated a positive patient safety culture, and experience of clinical 
governance and accreditation created an environment in which clinical governance was 
understood and accepted. Based on the evaluation of culture and the stakeholder analysis, 
the level of resistance expected was relatively low, and the principle challenge was to create 
strategic alignment with operational management. The strategic analysis established a 
framework for planning engagement and building commitment and motivation for the project 
at all levels which has been shown to increase the likelihood of success (Harlos et al., 2012; 
HSE, 2008; Ovreveit et al., 2012) 
 
3.2.2 Gap analysis, project impact and project initiation  
The expected impact of the change on the service was assessed in order to understand what 
it might mean for staff, and to predict and pre-empt unwanted results. At a basic level the 
change would require work and time from the change agent with support of the management 
team to design, plan and implement the proposed clinical governance system. This was 
expected to fit within the existing resources, with time being made available as needed 
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through prioritisation of tasks. For the operational management it would result in a more 
clearly defined service, but potentially at the cost of flexibility in responding to client requests, 
and increased cost per patient. The resource cost of clinical oversight processes was 
estimated based on assumed 5% utilisation which were agreed subject to ongoing monitoring.  
At the level of service delivery it would involve changes to practice for nursing and medical 
staff with a new set of processes and responsibilities. For the nursing organisation managers 
and the wellness managers it would create new tasks around the gathering and management 
of quality data and audit. More time would be spent on reviewing and analysing quality data, 
promoting direct responsibility for the service, which was overdue. The change was not 
expected to have a significant impact outside the service.   
Prior to the change project there were quality assurance processes in place in the external 
nursing organisation, including incident and complaint reporting systems, standard operating 
procedures, and informal but effective internal quality management. However there was no 
integration with the wellness department, and no coherent quality and safety management 
across the service which was growing rapidly. The first step towards establishing a project 
plan was to review the existing state. The findings (appendix 4) were presented to clinical and 
operational management, during which the business case was reviewed, and the scope of the 
project was outlined. There was general agreement regarding nature of the deficits and risks 
identified, though assessments of the order of priorities and the level of risk varied. Against a 
background of a very low organisational appetite for clinical risk, and strong senior 
management support for ensuring clinical and clinical governance best practice, the project 
was approved, and a provisional timeframe of nine months was agreed for design and 
implementation. 
 
3.3 Planning 
3.3.1 Building commitment 
The change envisioned the creation of a well-defined and risk-managed service, providing 
safe effective care, without large associated costs, which was positioned for growth, 
development and accreditation. Effective ‘linkages’ and ‘networks’ are identified by Harlos 
et al. (2012) as factors promoting successful change. In order to secure ‘buy in’ and build a 
shared vision for the change, and to understand the level and type of resistance to the 
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project, a process of consultation and communication was undertaken. Appendix 5 describes 
the communication plan, including the approach to eliciting feedback from stakeholders, 
describing what the changes would mean, and where the value of the change lay, and to 
collaboratively exploring the implications for the design of the clinical governance 
components. An internal stakeholder committee was formed with twice monthly meetings to 
plan and implement the change, as identified by Ovreveit et al. (2012), as a success factor, 
while the change agent liaised directly with the clinical and operational managers of the 
external nursing provider. At each planning step the vision and the drivers were reviewed and 
articulated as described by Hastings et al. (2014) and Avolio et al. (2009). The leverage 
points for change identified in the strategy analysis were applied selectively to show how the 
change supported stakeholder needs and organisational fit (Harlos, et al., 2012). The 
leadership approach adopted was based on the model of engaging leadership proposed by 
Alimo-Metcalfe and Alban-Metcalfe (2008, 2010).   
Resistance emerged in the area of cost, as predicted by Som (2009), as well as around 
resourcing and service flexibility, but was less than expected. The clinical drivers of risk 
management and best practice were accepted, as was support for the change as 
communicated by senior management. There was agreement about the potential benefits of 
defining the service and gathering data for quality and management information purposes, 
and of the longer term goal of accreditation. Operational staff administering the service 
experienced the difficulties posed by the current status and were supportive of the vision and 
approach, but had a realistic understanding of the available resources, and reservations 
about the scope of the project. Nursing management were entirely supportive of the vision 
and approach, had a similar assessment of the urgency of the change, and were eager to 
progress with planning and implementation. The mangers of the external nursing organisation 
took on a clear leadership role in developing and applying the changes at the level of service 
delivery, illustrating distributed leadership (West et al., 2014). 
 A collaborative approach to design ensured that the final systems were fit for purpose, 
avoided excessive resource impact, and minimised unintended consequences as advised by 
Dixon-Woods et al. (2012) and Ovreveit et al. (2012). Involving doctors in the service was a 
novel step. The medical team largely supported the project, which was an important driver in 
itself, as described by Ovreveit et al. and West et al. (2014), and the rationale for the change 
was consistent with the medical subculture, providing further support as proposed by Scott et 
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al. (2003a, 2003b) and Davies (2001). Ensuring that time was allocated for clinical oversight 
roles, as suggested by Hastings et al. (2014), and that the process was robust and medico-
legally sound was essential to retain support. The nature and scope of the change project 
was communicated over a period of 2 months through regular clinical meetings, and as the 
design progressed their role and involvement was explored collaboratively.  
 
3.3.2 Determining the detail of the change 
Ovreveit et al. (2012) emphasise the importance of rigorous planning from the outset as a 
predictor of successful change. The specific objectives and the desired outcomes were 
determined through review of the evidence supporting best practice in clinical governance 
(Appendix 1) and the resulting project plan is detailed in Appendix 6. Table 3 compares the 
baseline status with the envisioned destination. Detailed planning of the project made use of 
the approach described by PRINCE2 (OGC, 2005). In order to anchor the project in time, a 
Gantt chart was developed (Appendix 7), which allowed monitoring of progress against 
targets, preserved a strategic focus, and created opportunities for reflection and adaptation of 
the strategy. A six month review was built into the plan and a risk assessment for the change 
project was conducted as recommended by PRINCE2, which allowed identification and pro-
active management of risks (Appendix 8). 
Three approaches were prioritised: communication (Harlos et al., 2012), collaborative design 
(Ovreveit et al., 2012) and valuing resistance (Ford & D’Amelio, 2008). The final design 
needed to be clinically and medico-legally acceptable, operationally workable and tolerable in 
cost. The scarcity of resources meant that in practice the change agent developed a detailed 
draft proposal for review. In some cases this was accepted with minimal change. In other 
cases substantial reworking was required, either because the proposal was unacceptable or 
unworkable. Where feasible any of the more complex changes were approached as a pilot.  
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Table 2. Comparison of clinical governance at baseline with the vision for change 
Before change After change 
No written, structured clinical or 
operational governance 
Approved clinical governance document 
and operational process document 
Simple booking process Booking linked to setting expectations 
Questionnaire based lifestyle 
evaluation 
Standard evidence based assessment 
based on SOPs 
Biometric measurement and point of 
care tests 
Standardised assessment based on SOPs 
Unstructured nurse delivered 
lifestyle consultation 
Nurse delivered evidence based lifestyle 
and behaviour change consultation 
Nurse fully responsible for care Nurse responsible for care with doctor on 
call for advice and review of complex cases. 
Minimal documentation of 
assessment and rudimentary 
medical records management 
Clear documentation standards and 
effective medical records management 
No clinical audit Clinical audit program linked to quality 
management structures and processes 
Minimal gathering or reporting of 
quality data 
Structured and sustainable quality data 
gathering and reporting process 
No centralised or integrated quality 
management 
Structures and processes supporting 
integrated management of quality data and 
issues 
Automated report Escalation of significant or multiple risk 
factors 
No follow up Communication with GP if indicated 
No service user feedback Patient satisfaction survey 
 
The service clinical governance policy document was drafted over two months with reference 
to the findings of the literature review, the HSE clinical governance matrix (HSE, 2012) and 
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JCI accreditation standards (JCI, 2015). Three drafts were circulated for stakeholder review. 
This extended over a further three months following which it was signed off by clinical, 
operational and senior management in December 2014. This formal, approved document 
underpinned and supported the change process as described by (Greenhalgh et al., 2012). 
Changes to documentation of nurse consultations using a revised template were required to 
support clinical audit and conformance with medico-legal best practice (HSE, 2012; 2010). 
Management protocols for urgent or high risk cases were defined, combining nurse escalation 
of high risk screening cases for the doctor’s attention based on set criteria, with a doctor on 
call in a telephone support role. These were piloted by a small group of doctors.  The main 
concerns to emerge were defining responsibility for patient care, and ensuring protected time. 
A process for reporting incidents and complaints was drafted in conjunction with the nursing 
team, and an operational SOP was drafted for development by the operations team, in line 
with the findings of Ovreveit et al. (2012) regarding the importance of combined clinical and 
operational involvement in design and implementation as a predictor of success. Documents 
defining the various processes passed through multiple cycles of stakeholder review, and the 
resulting amendments improved efficiency and clarity, supporting the approach of valuing 
resistance (Ford & D’Amelio, 2008) and the development of responsible followership (Grint & 
Holt, 2011).  
Audit tools and plans were drafted following the advice of Copeland (2005) and the HSE 
(2013), initially covering the nurse, doctor, and critical administration processes. A pilot audit 
of the nurse process audit was conducted by the change agent to validate the tools, and the 
results were presented at subsequent workshops. This allowed the templates to be refined. It 
also identified major difficulties in accessing the necessary data, as there was only the most 
rudimentary filing system. Nursing management were keen to take ownership of audit, as 
supported by Benjamin (2008) and HSE guidance (HSE, 2013). It was agreed that the nursing 
audit would be conducted quarterly, with results to be presented quarterly. A priority action 
was to improve medical records management, which was undertaken by the administration 
staff as a one off corrective action with the intention that regular maintenance would make it 
sustainable.  
Two workshops were organised to disseminate the new policies and SOPs to the nurse team. 
The concepts underlying clinical governance were reviewed, and issues and concerns were 
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elicited. The response was generally positive. The most dubious reception was given to the 
proposed model for documentation of consultations, however the medico legal necessity was 
accepted, subject to a slight reduction in consultation numbers. Potential problems with the 
new system were acknowledged, as advised by Ford and D’Amelio (2008) and Smollen 
(2013) to maintain the credibility of the change process, and agreement to trial the new 
processes was secured.  
Regular stakeholder meetings were held to progress planning and implementation as 
recommended by Ovreveit et al. (2012) as an important feature of successful projects. Over 
the first three months good progress was made, while communication with nursing providers 
was maintained via the change agent. However in Autumn of 2014 ever more meetings were 
cancelled, resulting in disjointed communication between the nursing and operational 
management, and progress on joint clinical-operational tasks stalled. In an effort to rebuild 
momentum a trial project to gather service user satisfaction data, was prioritised as a possible 
quick win as described by Kotter (1995), and was designed and implemented by one of the 
administration team.  
 
3.4 Implementation 
Between June and December 2014 components of the change were implemented as they 
became ready (Appendix 6). The change plan was reviewed regularly at clinical team 
meetings, and dedicated workshops as part of the communication plan ensured that the 
change was visible and understood, and helped to create and sustain momentum for the 
project as described by the HSE model (HSE, 2008). Planning, implementation and revision 
of plans overlapped for different aspects of the project. Rapid progress was made on 
developing the clinical processes and SOPs, and tangible changes were made within the 
service at an early stage. This was facilitated by distributed leadership within the nursing 
management as highlighted by Grint and Holt (2011) and the Kings Fund (2011; 2012), and 
by the collaborative planning approach which minimised unintended consequences as 
described by Ovreveit et al. (2012), combined with the cultural alignment of the changes 
(Harlos et al., 2012). Initial audits were completed on time, however inefficient medical 
records management made the audit very resource intensive and not sustainable in that form. 
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The major problem was the lack of operational progress. There was still no written process 
outline, medical records were not being filed making further audit impossible, and handover of 
information was inadequate. The momentum was very unbalanced, with clinical leadership 
and frontline staff progressing rapidly, but frustrated with the lack of operational progress to 
support the changes. The initial diagnosis was a lack of urgency and commitment to the 
project at operational level. At a heated meeting the drivers of the change were again 
reviewed and possible resistance explored. It emerged that despite solid commitment and 
enduring optimism there was simply no one to work on clinical governance development.  The 
‘pull’ exerted by progress at the clinical end had exposed gaps in existing operational 
resourcing. Due to growth in demand and activity administrators were nearly full time on site 
and struggling to keep up basic operational administration, while management struggled with 
multiple conflicting priorities, and an unsustainable amount of the change agent’s time was 
spent on the project. These issues underlined the importance of joint clinical-operational 
implementation (Ovreveit et al., 2012), but also the criticality of adequate resourcing (Esain et 
al., 2012; Groene et al., 2010). At the progress review December 2014 and it became 
apparent that the project might stall entirely.  
As a first step these concerns were presented to senior operational management stressing 
the risk to the entire service, let alone the clinical governance project, as a result of under-
resourcing. This coincided with a new development project for the service, and recurring 
operational issues meant that resourcing was already causing concern. A business case for a 
new service manager and two additional administration staff was approved and they were 
recruited by February 2014.   
The second step was to challenge the model of parallel governance structures. Separate 
structures resulted in a lack of ownership for important areas of the service. The semi-
detached status of the service resulted in poor communication, confusion and erosion of 
accountability. Finally the lack of administration and management resources meant that 
separate quality management structures were unworkable. The alternative was to integrate 
the service into the wellness department quality management system, thus creating the 
linkages that have been shown to support sustainability (Greenhalgh et al., 2012; Harlos et 
al., 2012). There was some concern about increased risk to the department’s accreditation 
status, however in January 2015 the change was approved and implemented. The terms of 
reference of the management and quality committees were amended, service issues were 
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placed as a standing item on the meeting agendas, and the governance policy document was 
changed to reflect this. 
The third step was to prioritise an operational process document to clarify roles, tasks and 
responsibilities and act as a manual for induction of new administration staff, while 
standardising delivery of the service. The change agent mapped the service in terms of 
information flow, tasks and responsibilities, ownership was given to the new service manager 
and an advanced draft was presented for review at the end of February 2015. 
The final step was to address medical records management. The service had always been 
paper based, which was a drain on scarce resources. IT support had been considered but 
never pursued. Health IT had not emerged as a theme from the literature review on clinical 
governance implementation, and was not an obvious requirement for the project. The 
difficulties the IT deficit posed were primarily operational, however good clinical practice 
required effective records management, while audit required data to be accessible, and these 
two issues brought HIT onto the clinical governance agenda. An interim solution of scanning 
and indexing provided a rudimentary medical records structure, which was implemented in 
March 2014, while developing an IT framework for the service was added to a wider IT reform 
project in the department.  
 
3.5 Mainstreaming 
These final four changes to the system appeared substantial, however by the time they were 
identified and addressed, the preceding change process had brought the service to a point 
where they were seen as logical and inevitable. As a result there was immediate engagement 
and minimal resistance, and other than the complex problem of addressing IT needs, they 
were implemented very quickly. The ability to adapt implementation in response to changes in 
context is identified as vital to build sustainability (Ovreveit, 2011; Scheirer & Deering, 2011). 
A further result was that the service now benefited from a structured data driven approach to 
quality management, planning and development, which created pressure to produce reliable 
data to inform key performance indicators (KPIs). Demands for quality and operational data 
from the regular management and quality meetings exerted ‘pull’ and incentivised 
maintenance of processes, emphasising the effect of the linkages described by Greenhalgh et 
al. (2012). Careful planning and collaborative design, along with ongoing review and 
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communication with stakeholders meant that unintended consequences were identified and 
addressed early. Nursing management provided strong leadership for clinical governance, 
while the integration of the service into the department increased the urgency around formal 
accreditation, and provided continued momentum. At a service delivery level the changes 
were seen as positive and not too problematic and had bedded down well. At a final meeting 
in April 2015 the success of the project and the vital contribution of all participants was 
formally acknowledged, and outstanding issues were transferred to the agendas of ongoing 
projects. 
 
3.6 Conclusion 
The project was ambitious, however by the end of March 2015 most of its objectives 
appeared to have been at least partially attained. The change management approach taken 
allowed dynamic adaptation to changing context and emergent issues. Evidence identified by 
the literature review provided valuable guidance, and was largely confirmed by experience in 
practice. Barriers to sustainability had been addressed, and though not assured, the prospect 
for sustainability was positive. Implementation of clinical governance has been undertaken in 
many settings, however for such systems to create meaningful improvements in care they 
must be effectively implemented (Ovreveit, 2002). The HSE change model emphasises the 
importance of structured evaluation of change projects, and the next chapter describes the 
evaluation of the project and presents the results that evaluation. 
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Chapter 4: Evaluation 
4.1 Introduction 
Evaluation is “the systematic examination and assessment of the features of an initiative and 
its effects, in order to produce information that can be used by those who have an interest in 
its improvement or effectiveness” (WHO, 1998). The purpose of evaluating change projects is 
to establish whether the change took place, whether it had the intended effect, and to learn 
from the successes and failures of the project. This chapter describes the rationale and 
approach taken, and presents the results of the evaluation.  
  
4.2 Significance of Healthcare Evaluation 
Healthcare evaluation has been described as being like the ‘Wild West’ (Provonost et al., 
2008), with a plethora of local measures and absence of validation or generalisability 
(Provonost et al., 2006). The vital importance of ensuring safety in healthcare, and of 
ensuring that interventions are effective and justify the associated costs demands robust 
evaluation (Ovreveit, 2002). For healthcare interventions to generate improved outcomes pre-
supposes that the structures and processes underpinning those interventions have actually 
been implemented (Ovretveit, 2002). The importance of evaluating both implementation and 
outcomes of improvement projects is a recurring theme (Provonost et al., 2006). Ovreviet 
(2002) and van den Huevel et al. (2013) describe the practical and methodological difficulties 
of evaluating healthcare innovations, including long timescales for implementation, competing 
priorities, multiple confounding factors, and lack of standardised measures and success 
criteria. Evaluation frameworks are a partial answer to ensuring meaningful and valid 
measures are used (e.g. Groene et al., 2010; HIQA, 2013; Lombrail, 2008; Parry et al., 2013). 
Greenhalgh et al. (2012) review the need for a system-dynamic evaluation which recognises 
the evolving nature of change projects and focuses on the impact of innovations rather than 
static evaluation of the original intended goals and activities. The HSE change model stresses 
the importance of evaluating healthcare improvement projects and of analysing and 
disseminating the results to ensure organisational learning occurs (HSE, 2008).  
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4.3 Evaluation 
4.3.1 Aims  
The first aim of the evaluation was to measure the implementation and functioning of the 
clinical governance system to establish whether implementation had resulted in the intended 
process changes, and whether process changes had resulted in the intended outcomes. The 
second aim was to analyse the change in terms of system design, change approach, 
leadership approach and user acceptance. 
 
4.3.2 Methods and Measures 
The framework proposed by Donabedian (1988) permeates healthcare evaluation, and 
examines structure, process and outcome in the context of a definition of quality. He does not 
assign a higher validity to measurement of process or outcome, but stresses the need for an 
established causal link between these components. Parry et al. (2013) describe this causal 
link as the program theory, composed of content theory (why process change should lead to 
improved outcomes) and execution theory (how the intervention leads to process change). 
Parry links evaluation to Kirkpatrick’s model of evaluation (Figure 3) incorporating learning, 
behaviour change as a result of learning, and the result of behaviour change for 
organisational effectiveness (Parry et al., 2013). To evaluate the effectiveness of the 
execution theory, learning and its translation into behaviour change must be measured 
(Kirkpatrick stage 2 and 3), while evaluation of the content theory focuses on the link between 
process change and outcome (Kirkpatrick stage 3 and 4). The evaluation framework used for 
this project was based on Parry’s model, with reference to Donabedian and Kirkpatrick.  
The program model of clinical governance implementation was based on best practice in 
clinical governance (content theory), combined with four key themes supporting 
implementation (execution theory).  The content model could be summarised as: ‘Clear 
accountability, evidence based practice, clinical risk management and monitoring of 
standards of practice, incidents and patient satisfaction, contribute to creation and 
maintenance of a high quality service’. The execution theory states that: ‘cultural alignment, 
effective leadership, adequate resourcing and a combined top-down and bottom-up approach 
to change promote successful implementation of clinical governance’.  
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Figure 3: Kirkpatrick’s Evaluation Model (after www.kirkpatrickpartners.com, accessed 
September 2014)  
 
Ovreveit (2002) describes those evaluation methods most applicable to healthcare, which 
was used to design the evaluation for the project. Descriptive evaluation obtains information 
from stakeholders based on their expert knowledge of the service, its risks and the impact of 
changes. Audit designs evaluate implementation of a process against a standard, on the 
assumption that following a defined protocol will result in improved outcomes. Before and 
after designs evaluate the working of the intervention target before and after the intervention. 
Retrospective theory testing (e.g. prediction testing survey) is used to test theoretical success 
factors (Ovreveit, 2002). The evaluation combined objective and subjective, and qualitative 
and quantitative measures, and was conducted principally from an organisational and service 
provider perspective. Objectives, success criteria, data sources and measures are described 
in Table 3. Implementation was evaluated using dual service data sources (daily activity 
reports and clinical documentation systems) which were gathered and collated by hand, and 
cross referenced with audit results to ensure processes were working as intended, and did 
not represent a ‘paper exercise’.  
Audits were designed with reference to the HSE’s ‘A Practical Guide to Clinical Audit’ (HSE, 
2013b). The audit program was designed to evaluate patient care from initial assessment, 
through referral to the creation of a patient medical report. Audit tools were designed for 
nursing, medical and administrative aspects of the service, to evaluate the quality of service 
provision against SOPs, compliance with referral criteria, documentation and follow up (see 
appendix 10). 
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Table 3. Evaluation Plan 
 Objective What will 
success look 
like? 
Measure Data source Evaluation 
design 
1 Governance 
document 
An approved 
framework 
document which 
meets HSE 
standards 
Number of 
standards met out 
of 36 
Document Audit 
2 Establish Incident 
& complaint 
reporting and 
management 
Process 
Daily reporting of 
I & C by 
screening project 
Number of 
service activity 
reports, incident 
reports and 
complaint reports 
received 
Service activity 
reports 
Incident reports 
Complaint reports 
Before-After 
3 Design and 
implement 
gathering of 
service user views  
 
Feedback 
obtained from 
5% of service 
users each 
quarter 
Response rate On-line patient 
satisfaction survey 
Before-After 
4 Establish 
stakeholder 
coalition and 
quality 
management 
structures  
Regular 
meetings 
Management of 
quality and 
safety issues 
Number of 
meetings vs. 
planned 
Number of 
quality/safety 
issues addressed 
Meeting calendar 
 
 
Meeting minutes 
Audit  
 
 
Before-After 
5 Establish and 
implement  clinical 
oversight 
structures and 
processes to 
manage clinical 
risk  
Compliance with 
SOPs. User 
acceptance 
Utilisation rates 
for doctor on call 
and referrals 
 
Compliance rate 
with SOP 
User satisfaction 
with process 
Service activity 
reports and 
clinical 
documentation 
Clinical audit 
results 
User acceptance 
survey 
Before-After  
 
 
 
Clinical Audit 
 
Descriptive 
 
6 Establish Clinical 
Audit program to 
ensure 
conformance with 
best practice 
policies and 
guidelines 
Audit of clinical 
practice 
conducted and 
reported 
quarterly 
Audits completed 
vs. plan 
Clinical Audit 
results 
 
Audits schedule 
 
Anonymised 
patient record 
Before-After 
 
Clinical Audit 
7 Evaluate 
implementation 
and change 
management of 
project objectives 
Live, functioning 
sustainable 
clinical 
governance 
structures and 
processes 
Perceived service 
safety, user 
acceptance, 
perception of 
change process 
Measures 1-6 
Project Gantt Chart 
User survey 
 
 
 
Data from 
measures 1-6 
Before-After 
Descriptive 
Retrospective 
theory testing 
 
Multiple 
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The sample size for audit of service delivery by nursing staff was chosen to meet the 95% 
confidence interval, which is a recognised statistical standard, giving a 95% probability of 
identifying consistent patterns of non-conformance. Sample size was determined using the 
Raosoft statistical calculator (www.raosoft.com/samplesize.html, accessed Sept 2014). The 
suggested sample size was around 400 per year, and it was planned to audit 100 records per 
quarter as an achievable goal. Records were selected by stratified random sampling by date 
and healthcare provider.  No identifying patient information was used. Any audit based on 
review of documentation as a surrogate for practice is necessarily limited, however resource 
limitations dictated this approach. Audit was conducted by nursing management and a 
member of the medical team respectively.  
Measurement of project outcomes in order to verify the content theory was challenging, as 
warned by Donabedian (1988) and Ovreveit (2002). The vision was of a well-defined and risk-
managed service, providing safe effective care, without large associated costs, which was 
positioned for growth, development and accreditation.  These outcomes were evaluated 
through a semi-quantitative survey of user acceptance, perceived improvements in safety, 
system effectiveness, resource use, and strategic alignment. The same approach was used 
to evaluate aspects of change management and leadership. The survey was based on the 
staff safety survey designed by the ARQH (2013), heavily adapted to assess specific aspects 
of the change project. The survey was initially tested on two external subjects and refined 
based on the feedback. A Likert scale was used, allowing aggregation of numerical results, 
and free commentary allowed underlying issues and dissenting voices to be explored. The 
survey was distributed to all staff members, representing a purposive approach as 
recommended by Pope (2002). It was accompanied by an explanatory leaflet and consent 
form. Results were anonymous and were collected through a ‘gatekeeper’ representing each 
group, to protect confidentiality. The survey required modification according to the role of 
respondents based on feedback from initial groups surveyed. As a result the responses are 
not fully standardised, which is a weakness of the evaluation. The overall response rate was 
54%. Appendix 12 shows a summary of the results and responses rate by group. 
4.3.3 Results 
Objective 1: The clinical governance policy document was approved by senior management 
and became operational in December 2014. It was audited against the HSE clinical 
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governance development checklist (HSE 2012) to ensure conformance with best practice as 
established in the literature review. Of thirty six standards three were deemed not applicable 
as the service is not part of the public system. Of the remaining thirty three standards, thirty 
one were met within the document (Figure 4). Two were deemed partly met, as the meaning 
was implicit in the governance structure and responsibilities but was not explicit in the 
document (see Appendix 9).  
Figure 4. Results of audit of clinical governance policy document against HSE clinical 
governance development checklist (HSE, 2012) 
 
 
Objective 2: Until June 2014 incidents and complaints were reported verbally or by email, 
however data was never centrally recorded, analysed or addressed. In late 2013 a formal 
policy for reporting incidents and complaints was trialled, however there was little change in 
the rate of reporting or the availability of data. The process was adapted in July 2014, to 
facilitate on-site reporting through the daily activity reports from screening projects. From 
December 2014 all incidents and complaints reported were registered on the wellness 
department quality system so that they could be analysed and managed through the 
established quality structures. Figure 5 shows reporting rates over time and a step-wise 
improvement in reporting rates with each process refinement.  
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Figure 5. Incident and complaint reports received (Jun 2014- Feb 2015) 
 
 
Objective 3: Patient satisfaction data was gathered by establishing an online survey 
(appendix 11), the link to which was emailed to participants via company HR departments, 
following attendance at the program. The target was to obtain responses from 5% of service 
users. By the end of the project in February 2015 the response rate was 3.3%. By this 
measure objective 3 was only partly achieved, although a workable approach had been 
designed and tested, and valuable quality improvement data obtained regarding the wishes 
and needs of the patient group served. Due to the workplace setting of the service it was not 
possible to obtain consent to use this data to evaluate outcomes, or to obtain ethical approval 
for its use in a research project. Nonetheless the data gathering process was proven to be 
workable and effective and the information obtained will directly influence the further 
development of the service, and will contribute to ensuring the quality of the service provided. 
 
Objective 4: It was envisioned that the stakeholder steering group would evolve to take on a 
quality management role as quality data became available.  Figure 6 shows the number of 
actual versus planned meetings and the number of quality issues addressed over time. As an 
implementation committee the steering group functioned reasonably well. Steady progress 
was made as can be seen from the Project Gantt Chart (Appendix 6), however meetings were 
far less regular than intended. The effectiveness of the committee as a quality management 
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forum was assessed through a semi-quantitative evaluation of the minutes of its meetings, 
where each quality issue discussed was counted. The committee did not function effectively 
as a quality management forum until January 2015 when quality management for the service 
was integrated into the wider departmental quality management system, as seen in Figure 6.    
 
Figure 6: Planned versus actual stakeholder meetings and quality issues addressed (Jun 
2014- Feb 2015) 
 
 
The measures used to evaluate objectives 2-4 represent an objective evaluation of the reality 
of process and behaviour change (process output/transfer) as a result of the change project 
(Kirkpatrick level 3). The findings provide evidence that the processes were implemented and 
that they resulted in a change in practice. 
 
Objective 5: Evaluation of clinical oversight processes combined subjective qualitative 
evaluation of user perspectives, with objective quantitative evaluation through measurement 
of service data and clinical audit. The changes were evaluated on three levels. Satisfaction 
with training and user acceptance (Kirkpatrick level 1: reaction) is described in Table 7. 
Utilisation over time is illustrated in Figure 7, showing that the processes were in place and 
being used by the nursing and medical teams (Figure 7), demonstrating Kirkpatrick level 2 
(learning). Information was gathered on referrals and phone contacts using daily activity 
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reports which logged each contact, cross-checked against clinical documentation for 
verification. There was a 4% discrepancy. Spot checking showed that this was due to 
deficiencies in medical records management and the actual discordance rate was very low. 
The rate of referrals averaged 4.4%, within the predicted rate of 5% that had been budgeted 
for in the resource planning phase. Application of the processes to practice was confirmed by 
clinical audit, as described in table 4, showing that the processes were functioning as 
intended (Kirkpatrick level 3: transfer).  
 
Figure 7. Utilisation of clinical oversight processes (phone contact and referral for review) Jul 
2014- Feb 2015 
 
 
Objective 6: To design and implement regular audits of clinical practice  
Clinical audit is recognised as the best available tool to assess the quality and safety of 
healthcare (Benjamin, 2008).  It has been defined as ‘a quality improvement process that 
seeks to improve patient care and outcomes through a systematic review of care against 
explicit criteria and the implementation of change’ (NHS, 2005). Implementation of clinical 
audit was evaluated against the planned audit schedule, and as seen from Figure 8 audits 
were not conducted according to the plan. Limited resources combined with the lack of a 
45 
 
structured medical record management system meant that audits took longer than expected 
and stratified random sampling had to be replaced by opportunistic random sampling. 
Audit results were used to objectively evaluate compliance with clinical process SOPs as an 
objective measure of behaviour change. As table 4 shows, compliance with the standards set 
for the service was good, particularly in relation to potentially serious findings which were 
effectively identified, prioritised and managed. Conformance with processes for non-urgent 
referrals was lower but still good, and results for clinical documentation and consultation 
approach steadily improved. 
 
Figure 8. Audits completed versus plan. 
 
 
Of some concern was the unintended consequence of delays in issuing reports to patients. 
This was explored at medical team meetings, and lack of time was the key issue, raising 
questions about the sustainability of the process. In addition questions were raised about the 
value of the review as it did not add decision making or follow-up to the assessment. This was 
identified late in the project, and prompted significant re-engineering of the referral process 
into the future. 
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Table 4. Clinical Audit: % conformance with clinical consultation and referral processes 
 
 
 
 
 
 
 
 
 
 
*Medical records organisation not adequate to evaluate 
Objective 7: Measurement of project outcomes was limited by access to data and the short 
time-scale of the project, and was based on a purposive stakeholder survey. Three aspects of 
the survey are presented in tables 5, 6 and 7. For ease of comparison results were converted 
to a five point scale and percentages. Actual scales and results are given in appendix 10.  
Perception of service safety was of particular interest, as frontline clinicians are the best 
people to assess what can go wrong (NPSA, 2004). The results suggest a service which, 
following the changes, is safe and risk managed. It also supports the view that the changes 
% Conformance with SOP Pilot audit 1st Audit 2nd Audit 
N= 20 104 94 
Nursing Documentation 
 
80% 93% Not done 
Nursing Consultation 
 
35% 53% Not done 
Non-urgent nursing referrals (written) 50% 82% 73% 
Nursing referrals (verbal/phone) Not 
available* 
Not 
available* 
100% 
Management of serious clinical issues None in 
sample 
None in 
sample 
100% 
N= N/A 61 96 
Medical documentation 
 
N/A 92% 100% 
Medical management of non-urgent 
referrals 
N/A 97% 89% 
Medical management of urgent referrals N/A Not 
available* 
100% 
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have made the service measurably safer. Interestingly it also illustrates differing perceptions 
of clinical risk and governance across different stakeholder groups. 
Table 5. Perceived service safety  
Service safety:    
Rate safety before and after 10=Excellent 
1= Dire 
10=Excellent 
1= Dire 
10=Excellent 
1= Dire 
Survey Group Nursing Medical Management 
Safety before 8.0 6.6 6.5 
Safety after 8.5 8.7 9.5 
Change in safety as a result of 
implementation 
+0.5 +2.1 +3.0 
Safety processes now adequate? 1=Yes 2=No   
Processes now adequate to ensure 
patient safety? 
1.1 1.0 1.0 
 
The survey showed strong agreement that the changes were positive for patients and for the 
service and were well aligned with longer term strategic objectives, that the design of the 
system was fit for purpose, and that the cost-benefit was positive. Responses regarding 
effectiveness of the quality management system were obtained before integration into existing 
quality management structures, and do not reflect later refinements of the system. There was 
general agreement that in hindsight the change was under-resourced. There was a positive 
perception that accreditation was a realistic longer term goal. 
Table 6. User acceptance, cost-benefit perception and strategic alignment  
Theme Average Score 
Clinical Governance System Design 5= Yes 1=No 
Is the system fit for purpose 4.3 (86%) 
Have the changes been positive for the service and its 
patients? 
4.5 (90%) 
Is the cost of the system justified? 4.0 (80%) 
Are the processes working as intended? 4.5 (90%) 
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Is Quality Management system effective 3.3 (66%) 
Were resources allocated to the change adequate? 1.6 (32%) 
Do the changes support the strategic role of the service? 4.8 (96%) 
Is the service in a position to apply for accreditation? 3.0 (60%) 
 
There was a positive perception of the approach taken to building a shared vision through 
effective communication and collaborative design and implementation. The results support 
the value of a bottom-up approach combined with devolved leadership in generating 
commitment. The responses also support the engaging leadership model used in developing 
a shared vision, collaboration and empowerment. 
 
Table 7. Communication, training, shared vision and empowerment  
Theme Average Score 
Communication and Change approach 5= Yes 1=No 
Was communication effective? 4.0 (80%) 
Was training effective? 3.9 (78%) 
Do you understand purpose of change? 4.3 (86%) 
Do you understand your role and responsibilities? 4.2 (84%) 
Did you feel able to affect the changes? 4.3 (86%) 
 
4.3.4 Dissemination Plan 
The importance of learning from improvement projects is emphasised by the HSE change 
model (HSE, 2008), and the importance of learning organisations is a consistent theme of 
organisational development (Greenfield et al., 2011; Greenhalgh et al., 2012; Harlos et al., 
2012). Aggregated results of user survey and audits were presented at nursing workshops 
and clinical team meetings as they became available during the project, and were used to 
guide changes to design, and quality improvement plans. Systemic issues identified were 
reviewed at ongoing stakeholder meetings, and a summary of the evaluation results was 
presented at the project closedown meeting, which was used to plan ongoing evaluation and 
identify information gaps.  
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4.4 Conclusion 
There is strong evidence from service data and clinical audit that the management and 
oversight structures and processes were implemented as designed, and were producing the 
intended outputs, confirming change effectiveness at Kirkpatrick’s level of learning and 
transfer, and supporting the validity of the execution theory (Parry et al., 2013). In addition, 
both the change strategy and the leadership approach were seen as effective by 
stakeholders. From a  stakeholder perspective the system was fit for purpose, and had a 
positive impact on service quality and safety, providing subjective support for the validity of 
the content theory and effectiveness at Kirkpatrick’s fourth level of ‘results’ (Parry et al., 
2013). The principle limitation of the evaluation was the lack of objective outcome measures. 
The timeframe was too short for meaningful evaluation of safety outcomes. Lack of reliable 
data limited cost benefit evaluation, and patient responses could not be used to evaluate 
service user outcomes as it was not practical to obtain consent for research in an employee 
setting. Improvements in data collection as a result of the project will allow prospective 
evaluation of safety and cost-benefit, which will be essential to support sustainability. The 
implication of the results in the context of the change process are examined further in chapter 
five. 
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Chapter 5: Discussion 
5.1 Introduction 
The aim of this project was to implement a system of clinical governance in a workplace 
health screening service, which had evolved organically and without substantial oversight of 
clinical safety and quality. The guiding principles and core components of the system were 
distilled from a review of seminal papers and reports, from which a set of essential structures 
and processes were established which defined the scope of the project. The importance of 
effective implementation of clinical governance echoes through the literature of healthcare 
improvement, and evidence was identified for four key approaches which optimise the 
likelihood of success, namely a supportive culture, effective leadership, an appropriate 
change approach and adequate resourcing. This chapter will examine the impact of the 
project on the service and its stakeholders, the change approach used and the findings of the 
project in relation to the theory and practice of change management and clinical governance. 
It will evaluate some of the strengths and limitations of the project approach, and will attempt 
to identify learnings relevant to the service in which the project took place and to the wider 
healthcare environment.  
5.2 Project Impact 
Within the framework proposed by Parry et al. (2013) the implementation approach was 
effective (Figure 9). The evaluation supports the validity of the execution theory developed 
through review of research literature and best practice in clinical governance implementation, 
and the effectiveness of the implementation approach using an established organisational 
development change model (HSE, 2008), combined with project-related research evidence as 
highlighted by Ovreveit et al. (2012). The link between process change and improvements in 
outcomes was established using a descriptive evaluation as described by Ovreveit (2002). 
Despite the limitations of this approach it showed a definite perception that the intended 
outcomes of service safety and service quality had improved as a result of the change project.  
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Figure 9. Percentage of project objectives achieved 
 
A supporting governance policy was in place to support sustainability as described by 
Greenhalgh et al. (2012). Effective gathering, analysis and management of quality data had 
been implemented and integrated into established structures as recommended by all 
established clinical governance frameworks and standards (e.g. HSE, 2012; HIQA, 2012). 
Clinical oversight processes were in place and functioning as intended. The intended process 
for gathering data on service user experience had been designed and successfully trialled, 
although the objective of surveying 5% of users had not been met. Clinical audit had been 
designed and successfully implemented, however it was not yet sustainable, and lagged 
behind the planned targets. The outcome measures which could be evaluated within the 
scope of the project were positive. The leadership approach and change management 
approach were seen to have been effective, and the system design was perceived as 
workable and fit for purpose without imposing an excessive workload, supporting 
sustainability as described by Ovreveit et al. (2012) and Dixon-Woods et al. (2012). There 
was evidence from the stakeholder survey that the changes were effective and valued, and at 
the level of service delivery that the processes had embedded and become part of how things 
were done. The financial impact of the change was difficult to estimate due to the lack of 
detailed costing data, however those aspects of the change which could be costed were 
delivered within the estimated budget. It was equally difficult to estimate the financial benefits 
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arising from the change, however these include opportunities for growth and development of 
the service, delivery of robust quality and management information, and operational clarity 
which improved the efficiency of service delivery. 
 
5.3 Theory and Practice: Learnings of the Project 
Strategic Analysis: Careful preparation and planning has been consistently identified as a 
predictor of success in change management (Dixon-Woods et al., 2012; HSE, 2008; NICE, 
2007; Ovreveit et al., 2012)). Strategic analysis as part of the initiation phase provided vital 
landmarks from which to navigate the change, and identified a range of potential levers 
through which engagement and synergism could be secured, including low corporate 
tolerance for clinical risk and reputational risk, external regulatory developments and 
alignment with corporate business objectives. Internal levers included the risks and 
opportunities related to accreditation, benchmarking against the standards and culture of 
existing services, awareness of ‘near miss’ incidents, and good ethical and medico-legal 
practice. Service improvements resulting from increased clinical and operational clarity 
offered opportunities for sustainable growth and development as well as managing risks. 
These levers provided a menu of options for creating the ‘viable political rhetoric’ described by 
Bryson (2004) capable of appealing to a wide range of stakeholder interests, and addressing 
potential sources of resistance. It also clarified the context of the project in terms of power 
and politics, the structure and culture of the organisation, the stakeholder approach needed to 
develop strategic alignment, and enabled the development of a coherent vision for the 
change.  
Power and Politics: Arendt has described politics as activity which rearranges relations 
between people and the distribution of goods, while power is the capacity to influence other 
actors with these political interests in mind (Arendt, as cited in Fleming & Spicer, 2014). 
Fleming and Spicer (2014) review the role of power in organisations, and describe the 
principle sources of power as those of formal authority, control of scarce resources and 
control of uncertainty.  
Senior management with overall accountability for the department supported the change on 
clinical, ethical and medico-legal grounds, providing an important source of power. The 
change agent had formal authority, combined with the expert power described by French and 
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Raven (1959), and occupied a linking network position in the change process (Borgatti et al., 
2009; Fleming & Spicer, 2014) which gave control over important sources of uncertainty, such 
as information flow and engagement of the medical and nursing team. Understanding the 
sources of power and the relevant organisational politics guided strategic alignment, however 
power was not used deliberately as part of the change process, and the tactics of 
consultation, exchange and persuasion used were more in keeping with engaging leadership 
than power politics. 
Stakeholder management: Structured use of tools for stakeholder analysis as suggested by 
Bryson (2004), d’Herbemont and Cesar (1998) and NHS (2008) enabled Bryson’s ‘viable 
political rhetoric’ (Bryson, 2004) to be effectively employed. The analysis predicted relatively 
little resistance, but low levels of engagement, which demanded an emphasis on leadership, 
developing a shared vision, and building commitment (West et al., 2014), alongside managing 
resistance. Consistent communication of the drivers of the change and benchmarking against 
existing services and clinical governance best practice undermined resistance, while a 
collaborative approach to designing structures and processes which were fit for purpose and 
resource-light, satisfied a wide range of stakeholder needs and encouraged the development 
of a shared vision as described by Harlos et al. (2012), Ovreveit et al. (2012), Dixon-woods et 
al. (2012) and Kotter and Slesinger (1995). Promoting alignment of objectives (clinical and 
operational excellence, opportunities for sustainable development and addressing 
accreditation risks and opportunities) gained significant commitment as advised by 
Greenhalgh et al. (2012).  
Resistance has come to be seen as a negative psychological phenomenon, and in their 
review Ford and D’Amelio (2008) make a strong case both for the inevitability, but also for a 
positive and beneficial interpretation of resistance. Resistance can represent legitimate 
dissent, based on a differing assessment of the cost-benefit of a change. It can also signal 
strong engagement and commitment to the service in which the change is taking place.  
The approach was taken of valuing resistance, listening to the message heard and acting on 
it. The result was a stronger more effective change through eliminating impractical and 
counterproductive aspects of the design and avoiding the unintended consequences 
described by Dixon-Woods et al. (2012). Valuing resistance built trust through a collaborative 
approach, and as Ford and D’Amelio (2008) and Smollan (2013) describe, converted 
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resistance into commitment. Ford and D’Amelio (2008) advise caution regarding the potential 
negative impact of the change agent themselves on resistance. This may happen through a 
negative expectation of stakeholders, deliberate or unintended misrepresentation of the 
change, breach of trust, or defensiveness in the face of resistance. The practical message of 
the need for self-awareness on the part of the change agent regarding their reaction to 
resistance, and their leadership style, guided the approach taken.  
Culture: Organisational culture was identified by the literature review as a key factor for 
implementation of clinical governance (Scally & Donaldson, 1998). The cultural analysis 
showed a positive and dynamic managerial culture combined with a well rooted culture of 
patient safety. As Carroll et al. (2004) have described, sensitive transposition of existing 
positive cultural traits from established departmental services into the employee wellness 
service facilitated development of the system and values of clinical governance, and proved 
to be a crucial enabler for the project as predicted by Greenfield et al. (2011) and Robinson et 
al. (2008). 
Vision and Leadership: A clear and shared vision is fundamental to successful change 
management (Harlos et al., 2012; HSE, 2008; Kotter, 1995; Young, 2009). The vision for the 
change, combined with analysis of the triggers and drivers of the change, stakeholder 
interests and the wider environmental context, was the motor for generating urgency and 
engagement (Kotter & Slesinger, 2008). It was also the foundation of a ‘viable political 
rhetoric’ (Bryson, 2004) capable of generating commitment and managing resistance.  
The vision was developed out of an evidence based review of the principles of clinical 
governance and its components, the ethical imperatives of clinical practice, and a strategic 
analysis of the drivers, resistors and influences on change. Synthesising these factors into a 
rational, coherent, evidence based vision, and communicating it clearly, was a central 
leadership function (Carroll & Quijada, 2004). It allowed potentially conflicting stakeholder 
perspectives to be aligned, which built commitment and limited self-interested resistance.  
The leadership model adopted was that of transformational and engaging leadership (Alimo-
Metcalfe & Alban-Metcalfe, 2008; 2012). The features of effective leadership described in 
these models form the basis of the ‘post-heroic leadership’ advocated by the Kings Fund 
(2011). They are in keeping with the ‘quiet leadership’ described by Dixon-Woods et al. 
(2012), and were also consistent with the management style of the change agent.  
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A collaborative approach to devising the system was a simple necessity if the project was to 
be sustainable. There were very real medico-legal, operational and resource concerns that 
needed to be understood and accepted in the planning process. West and Dawson suggest 
that leadership conducive to engagement in health services includes allowing autonomy, 
enabling use of a wide range of skills, giving ownership of tasks, and giving support and 
encouragement (West & Dawson, 2012). The perception of the change by participants 
confirm that there was a sense of participation and an ability to affect the form of the change. 
Shared ownership of the change promoted development of distributed leadership as 
described by Avolio et al. (2009) and West et al. (2014), which was highly effective within 
nursing management, and responsible followership (Grint and Holt, 2011), seen in the form of 
critical review by medical, nursing and operational staff.  
The role of the change agent needed to manifest the integrity of the change approach in order 
to secure and retain commitment across clinical and non-clinical groups (Ford & D’Amelio, 
2008).  It was also necessary to be aware of preconceptions and existing mental models in 
order to be open to novel and practical solutions (Ford & D’Amelio, 2008), while staying true 
to accepted best practice. Problems were presented in an honest forthright manner. 
Proactively identifying issues through active listening aimed to avoid misrepresenting the 
change (Ford & D’Amelio, 2008), and to channel energy into problem solving, while at the 
same time empowering and building trust. Seeing resistance as a positive force encouraged 
questioning and facilitated development of the change. 
Creating impetus meant finding and presenting solutions acceptable to all stakeholders in a 
balanced and timely manner, being open to and integrating multiple perspectives, and 
deciding at what point a solution was workable and acceptable. The nature of the change 
meant that solutions were seldom perfect, and a degree of risk taking was required as 
described by Carroll & Quijada (2004). The combination of consensus building, problem 
solving and conflict managing touches on multiple aspects of leadership theory, including 
Rittel and Weber’s ‘wicked problems’ (Grint & Holt, 2011; Rittel & Weber, 1973), risk-taking 
and decision-making advocated as part of the engaging leadership model (Alimo-Metcalfe, 
2008; Dawson & West, 2012) and transformational leadership (Bass, 1999). To synthesise 
input from multiple sources, create linkages, solve problems and generate strategic alignment 
is one of the challenges of leadership (Avolio et al., 2009; Carroll et al., 2004; The Kings 
Fund, 2011).  Challenging historical assumptions around dual quality management structures, 
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harnessing external forces to the change such as organisational risk appetite, accreditation 
and national regulatory changes, helped drive the project. Integration of inputs from 
stakeholders greatly strengthened the final system design, while ensuring ownership and 
sustainability.   
A basic concept in transformational leadership theory is that of inspiring people to transcend 
self-interest by appealing to higher order values. The project vision was the vehicle for the 
idealised influence and inspirational leadership described by Bass (1999) and Bass & Avolio 
(1996). In practice regularly articulating the vision and drivers for the change helped to 
maintain commitment and direction, and the survey evidence suggests that the vision was 
both accepted and endorsed by staff managing and negotiating the change, and was seen as 
a positive, justified and successful aim.  
The communication plan based on stakeholder analysis provided an evidence-based 
framework to transmit the vision effectively, and survey responses indicated that it was 
effective. The importance of clinician leadership as emphasised by Ovreveit et al. (2012) and 
many others, was evident. Representation of organisational values (Bohmer, 2012), insight 
into professional culture, specialist knowledge and a linking network position (Fleming & 
Spicer, 2014) resulting from clinician involvement enhanced the power available to the 
change and helped secure commitment across functional groups. 
The importance of leadership for the success of the project, and evidence from the 
stakeholder survey of the effectiveness of the leadership model adopted, supports the 
evidence for transformational and engaging leadership as an effective model for implementing 
change, building commitment, and developing responsible followership and distributed and 
multi-level leadership in healthcare change projects.  
 
Change approach: Literature evidence supports both a top down and a bottom up approach 
to implementing clinical governance. The experience of this project confirmed both 
approaches. High level support was an important driver for the development of a clinical 
governance system, and an important lever for lending urgency to the change. In practice the 
main approach was bottom up, through direct engagement with clinicians and clinical 
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managers delivering the service, and the administration staff who understood the processes, 
to design a system that was workable and acceptable to front-line staff.  
The development of dynamic distributed leadership was an important enabler (West et al., 
2014), and an engaged operational management and administration team, combined with 
pace-setting by the change agent, allowed the development of close working relationships as 
recommended by Dixon-Woods et al. (2012). The strength of this bottom-up approach was 
that it produced practical solutions, while avoiding the perception of an ‘imposed system’ 
(Paccioni et al., 2008). Involvement of clinicians at all levels contributed to the credibility of the 
project as suggested by the Kings Fund (2012) and Ovreveit et al. (2012).  
This combined approach agrees with the findings of Kelleher and McAuliff (2012), of the 
effectiveness of senior management commitment combined with a clinician-team based 
action learning approach. A team based approach, identified by Harlos et al. (2012) as a 
facilitator of knowledge translation, was not explored as part of this project. The dispersed 
nature of the service and its staff made formation of cross-functional teams difficult, while the 
short timescale of the project left limited scope for teams to mature. At the same time the 
degree of constructive collaboration in the project suggests that cross-functional teams would 
be an effective vehicle to develop the service (Humphrey & Aime, 2014). The results of the 
project show that a combined top down and  bottom up approach, which enables distributed, 
multi-level leadership and responsible followership as described by Avolio et al. (2009), The 
Kings Fund (2012), West et al. (2014) and Dixon-Woods et al. (2012), is effective. In a 
dispersed setting characterised by strong leadership capability this provides a viable 
alternative to the team based approach described by Kelleher and McAuliffe (2012), and 
resonates with the Kings Fund’s ‘post-heroic model of leadership’ in healthcare (The Kings 
Fund, 2011). 
Change Model: Change projects are rarely straightforward and use of structured change 
models have been shown to increase the likelihood of success (Ovreveit et al., 2012). Use of 
the HSE change model allowed a structure to be discerned, and facilitated system-based 
reflection on problems and barriers. The source of problems was often quite removed from 
where they manifested. For example the failure to conduct planned audits was due to 
increased service activity, resulting in lack of administration time to manage documentation. 
The solution was ultimately to implement an IT framework for the service. Competing priorities 
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prevented effective quality management, yet the solution was to challenge the assumption 
that parallel quality structures were needed. The change model provided the contextual 
understanding needed to look for solutions in less obvious places. It also promoted use of 
pilot changes (Coghlan & Brannock, 2010), which helped manage uncertainty by adapting 
changes in light of initial results. Combining the change model with evidence specific to 
clinical governance implementation added clarity and focus to the project (Oevreveit et al., 
2012). The HSE change model proved to be effective and comprehensive, and the only gap 
identified was the lack of focus on creating urgency. 
 
Resources: The literature on implementing clinical governance systems stresses the need to 
ensure adequate resources are available to implement the change (e.g. Degeling et al., 2004; 
Esain et al., 2010; Greenfield et al., 2012; Ovreveit, 2002). At the same time Dixon-Woods et 
al make the point that most initiatives need to be effectively resource-neutral to be sustainable 
(Dixon-Woods et al., 2012). The HSE change model emphasises the need to agree resource 
requirements at the initiation stage of a project (HSE, 2008). Prior agreement was secured for 
certain resources, such as allocating time for medical staff to participate in clinical oversight 
processes. The initial assumptions underlying these requirements proved valid, and ensured 
that they could be implemented effectively. However the resources needed to design and 
implement the changes were seriously underestimated. It was assumed that prioritising tasks 
would allow design and implementation to progress in tandem with regular workloads, as 
Ovreveit et al. (2012) found. From a clinical and nursing perspective this worked, though it 
resulted in progress being made in fits and starts. From an administration perspective it did 
not work, and it was compounded by an unrecognised deficit in resources needed to simply 
run the service. In addition the attempt to create parallel quality management structures was 
not an efficient use of existing resources. Closer collaboration with senior operational 
managers from the outset of the project might have identified the problem earlier, which was a 
weakness of the bottom-up approach taken, and highlights the crucial importance of rigorous 
planning at the initiation stage. 
 
Information technology (IT) was not intuitively a vital component of a clinical governance 
system, and was not identified by the literature review as an important factor. It was not part 
of the existing service process, and was not identified as an essential enabler or resource 
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requirement at the planning stage of the project. As a result implementation of important 
aspects of the project were delayed, and accessing data for evaluation measures was 
laborious and unsustainable. Lack of IT support also imposed operational weakness and 
opportunity costs which the change project exposed. In hindsight early recruitment of IT 
support would have made many aspects of the clinical governance project easier, however in 
reality the exposure of operational deficits was a necessary driver to secure resources for IT 
development. 
5.4 Sustainability and Future Direction 
Four serious threats to sustainability had been addressed: shortage of administration 
resources (Greenfield et al., 2011; Groene et al., 2010); absence of HIT infrastructure; lack of 
integration into existing management structures (Harlos et al., 2012); and lack of operational 
definition of the service (HSE, 2012; JCI, 2015). The changes were embedded in approved 
service documents as discussed by Greenhalgh et al. (2012), and the clinical processes had 
bedded down and matured over the preceding six months as demonstrated by the project 
evaluation. Integrating the employee wellness service into established quality management 
structures (as suggested by Dixon-Woods et al., 2012) was effective within the duration of the 
project. In keeping with the cyclic and continuing nature of change a number of issues 
remained open. Establishing a durable IT framework for the service to support clinical audit 
and quality management was devolved to a concurrent departmental project. Full 
implementation of patient surveys, credentialing, formal risk assessment, development of key 
performance indicators, progress towards accreditation, and exploring team based quality 
improvement remained outstanding. Robust evaluation of outcomes through cost benefit 
analysis, or a research type approach to improvements in patient health behaviours would 
confirm the value of the change. Revision of the medical referral process offers improved 
efficiency and effectiveness, but is likely to meet resistance, and represents a small change 
project in its own right. Ongoing monitoring of service data and clinical audit will be essential 
to ensure that the system is maintained, and will provide data for continuous quality 
improvement within the service, and longer term objective data regarding safety and quality 
outcomes.   
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5.5 Strengths and Limitations of the Project 
The project represented a significant, large scale change initiative, which generated important 
improvements for the service.  It providing extensive practical experience and learning about 
change management, leadership, planning and stakeholder management, and the successful 
implementation of the project supports the value of the positive learnings, while highlighting 
areas of deficiency and negative learnings. Effective use of research evidence underpinned 
both the change approach and the project design, and an evaluation method embedded in the 
project design, and based on a recognised evaluation framework, allowed robust measures of 
success. 
Limitations of the project relate to aspects of the evaluation design, and to the data available 
for the evaluation. Structured leadership evaluation, for example using the transformational 
leadership questionnaire (Alimo-Metcalfe & Alban-Metcalfe, 2001), would have provided more 
robust evidence regarding the application of theoretical leadership models to practice. Equally 
a formal evaluation of culture might have identified those aspects of positive culture which 
directly facilitated the change.  
The principle limitation was the lack of objective and long-term outcome measures to support 
real life effectiveness. This was partly due to the timescale of the project combined with the 
nature of the service, and limitations on data gathering and consent. An important weakness 
of the project was the result of lack of attention to resource and IT planning, which delayed full 
implementation of important aspects of the project. 
5.6 Conclusion and Recommendations  
Organisational change by its nature affects many people. Leading, negotiating with, and 
managing the people affected, and understanding their unique perspectives and requirements 
in the framework of a structured change model, was a seminal learning experience. Above all 
it emphasised the importance of leadership and vision, of preparation and planning, and of 
the human interactions inherent in changing the way things are done. It also emphasised the 
value of reflective practice, particularly in situations where there were no right answers.  
Harnessing the knowledge and experience that exists in the research literature in order to 
apply best practice to the change project was vital. It was a powerful lever for change, and a 
comforting support in a sometimes difficult environment. Analysis and awareness of the 
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norms of organisational subcultures allowed the change to be built by reinforcing positive 
cultural attributes, such as a concern for patient care, and a desire for clarity and good 
governance. The importance of the existing positive organisational and clinical culture for the 
success of the project cannot be overstated.  
Robust strategic analysis was essential to the development of an effective change 
management strategy and identified key levers for progressing the project and pre-empting 
and managing resistance. Using a defined change model provided a context for 
understanding the role and application of the strategic analysis to guide the change. The 
model also provided a framework for structured reflection, which facilitated the diagnosis of 
complex problems and the identification of less obvious solutions, and was a roadmap for 
making the change sustainable. The experience and outcomes of the project support the 
value and effectiveness of the HSE change model as a methodology for implementing 
healthcare interventions. 
The experience of the project underlined the fundamental importance of preparation and 
planning. That the project took longer, and required more effort than anticipated was due to 
neglect of basic planning elements. Resource needs were identified in the literature review as 
a key factor, but not given due attention. A lesson from the project was that although resource 
management is not intrinsically a clinical role, for any clinician managing a healthcare 
improvement project the ability to estimate and secure necessary resources is essential. An 
unexpected finding from the project was the importance of an effective IT infrastructure to 
support clinical governance and health service development.  
Vision and leadership were the engine of the project. Perhaps the most important learning 
from the project was the practical value of understanding and applying different aspects of 
leadership in a ‘post-heroic’ leadership role. The success of the project using an engaging 
leadership model adds to evidence for the effectiveness of transformational and engaging 
leadership theory in a healthcare setting. The existence of strong leadership capability, and 
the success of promoting and empowering leadership at multiple levels, provided much of the 
momentum for the change. The success of a combined bottom up and top down approach to 
change supports the findings of Kelleher and McAuliffe, and effective distributed leadership 
and responsible followership offered a viable alternative to the team based approach they 
describe in a similar healthcare setting.  
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The project achieved or partly achieved all of its objectives, and was adjudged to have been 
successful by all its stakeholders. Organisational change, and quality improvement do not 
have an end point, and many of the initiatives have evolved into projects in their own right. 
The experience of this project has had a profound influence on my approach to management, 
leadership and medicine, and will inform my practice for a long time to come. 
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Appendices 
Appendix 1: Principles and Key Components of Clinical Governance 
 
Problem Principle  ‘Crossing 
the 
Quality 
Chasm’ 
(Institute 
of 
Medicine, 
2001) 
Bristol 
Inquiry, 
2001 & 
‘The 
New 
NHS’ 
(DoH, 
1997) 
Lourdes 
Hospital Inquiry 
(DoHC 
2006)&‘Building 
a Culture of 
Patient Safety’ 
(DoHC, 2008) 
Francis 
Report, 2009 & 
‘A promise to 
learn a 
commitment to 
change’ (DOH, 
2013) 
Disregard of 
patient needs 
and rights. 
Focus on 
requirements of 
staff and 
system 
Patient-centred care 
& patient 
empowerment 
√ √ √ √ 
Awareness of 
vulnerable patients 
√ √  √ 
Effective complaint 
management 
  √ √ 
Ineffective or 
inappropriate 
care 
Effective/evidence 
based care 
√ √ √ √ 
Clinical Audit  √ √ √ 
Defined clinical 
quality standards 
 √ √ √ 
Minimum quality 
standards 
 √ √ √ 
Unacceptably 
high rate of 
medical error 
Systems approach to 
safety 
√ √  √ 
Medication safety  √ √  
Incident & event 
reporting 
 √ √ √ 
Timely & Efficient 
Care 
√ √  √ 
Competence 
assurance 
 √ √ √ 
Learning 
organisation  
 √ √ √ 
 
Unhealthy 
culture 
Responsibility & 
Accountability 
 √ √ √ 
Culture of openness 
& transparency 
√ √ √ √ 
Leadership √ √ √ √ 
Communication, 
cooperation & 
teamwork 
√ √   
Facilitators of 
high quality 
care 
Health Information 
Technology (HIT) 
√  √  
Effective 
Implementation  
   √ 
Adequate staff 
resources 
   √ 
73 
 
 
Appendix 2. Features of engaging leadership (after Carroll et al., 2004) 
Personal qualities and values 
 Being honest and consistent  
 Acting with integrity 
Engaging with individuals  
 Showing genuine concern  
 Being accessible  
 Enabling  
 Encouraging questioning 
Engaging the team/organisation  
 Supporting a developmental 
culture 
 Inspiring others  
 Focusing team effort  
 Being decisive; risk-taking 
Engaging stakeholders (moving 
forward together)  
 Building shared vision  
 Networking  
 Resolving complex problems  
 Facilitating change sensitively 
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Appendix 3: Strategic Analysis Tools 
Appendix 3a. PESTLE Analysis: Implementing Clinical governance in an employee 
wellness service  
Political 
 High profile failures of healthcare 
safety (Lourds Hospital, Halavita 
Panaver and others) 
 National focus on service quality and 
safety (HIQA, HSE, Quality and 
Safety Directorate) 
 Political pressure on health insurers 
to contain costs  
 Benchmark of HIQA National 
Standards 
Economical 
 Recession and cost containment 
pressure on private insurers 
 Increasing competition for corporate 
insurance contracts 
 Need for brand differentiation and added 
value. 
 Pressure to offer new and innovative 
‘screening’ services due to competition  
 Rapid service growth 
Social 
 Increase in chronic illness and need 
for preventive strategies 
 Increasing patient expectation of 
service quality. 
 Public demand for transparent quality 
assurance 
Technological 
 Change in clinical guidelines and 
recommendations for clinical best 
practice 
 IT increasing public access to health 
information and contributing to demand 
for reliable, effective services. 
Legal and Regulatory 
 Medical practitioners act and health 
and social care providers act- medico 
legal requirements (Medical Council 
and An Board Altranis) 
 International consensus on best 
practice in healthcare quality and 
safety (IHI, NHS) 
 Likely future extension of HIQA 
regulation to private healthcare 
services 
 JCI accreditation requirements 
Ethical 
 Ethical obligation to provide safe, high 
quality care 
 Increasing focus on patient-centred 
service delivery and patient 
empowerment and education. 
 Requirement for  confidentiality and data 
protection in setting of 
corporate/employer provided services 
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Appendix 3b: TOWS Analysis (Threats, Opportunities, Weaknesses, Strengths) 
 
 
 
 
 
 
 
 
  
 External opportunities: 
 Improve competitive 
position by providing 
quality assured JCI 
accredited service 
 Manage clinical risk to 
allow safe, sustainable 
growth of service 
 Proactively manage 
regulatory quality and 
safety requirements 
(future-proof) 
External threats: 
 Clinical adverse events, 
litigation, reputational 
damage in setting of poor 
service management 
 Unwanted regulatory 
attention 
 Loss JCI accreditation 
status 
 Loss of competitiveness 
due to inability to develop 
service 
Internal strengths: 
 High demand for service 
 Availability of high 
quality clinical and non-
clinical staff 
 Supportive high quality 
contracting partners 
 Established clinical 
governance model in 
other services and 
supportive culture 
SO 
Engage management and 
clinical and non-clinical staff 
and contractors to 
implement appropriate 
clinical governance and 
operational structure to 
provide quality assurance 
and facilitate accreditation 
and ensure regulatory 
compliance 
 
Build on supportive culture 
ST 
Build on existing expertise 
and culture to manage clinical 
and organisational risk and to 
optimise service quality and 
efficiency and increase 
competitiveness 
Internal weaknesses: 
 Lack of operational 
service structure ad 
resourcing model 
 Lack of structured 
clinical oversight 
 Lack of quality and 
safety management 
processes 
WO 
Design and implement 
Clinical oversight processes 
Quality and safety 
management processes 
Operational structures and 
processes 
WT 
Design and implement clinical 
governance policies and 
processes, and operational 
structures and processes to 
minimise clinical risk and 
increase efficiency and 
competitiveness  
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Appendix 3c. Force Field Analysis (Part 1 to 3) 
 
Part 1: Identification of principal driving and restraining forces  
 
DRIVING FORCES RESTRAINING FORCES 
Clinical, ethical and medico-legal requirement to 
manage clinical risk following transfer of 
corporate wellness services to medical 
Screening Department 
Concern about impact of quality assurance 
and management processes on service 
efficiency and profitability 
Near miss incidents highlighting potential safety 
risks 
Concern about reduced versatility of 
healthcare delivery service to respond rapidly 
to business demands due to implementation 
of clinically led protocols 
Non-conformance with EB best practice in 
service delivery 
Lack of sense of shared responsibility for 
clinical issues across operational 
management (lack of integrated governance 
structures) 
Concern of contracted service providers about 
lack of clinical oversight 
Lack of alignment of  clinical and operational 
goals and objective 
Need to maintain overall service accreditation 
with Joint Commission International following 
transfer of corporate wellness services 
Lack of resources to accommodate both 
operational and clinical governance 
requirements 
Organisational risk management structures and 
processes (low tolerance for clinical risk) 
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Appendix 3c, Part 2: Evaluation and prioritisation of driving and restraining forces   
RESTRAINING FORCES A 
Importance 
B 
Ease of  
Change 
A  * B Ranking 
Concern about impact of quality assurance and 
management processes on service efficiency 
and profitability 
4 2 8  
Concern about reduced versatility of healthcare 
delivery service to respond rapidly to business 
demands due to implementation of clinically led 
protocols 
3 3 9  
Lack of sense of shared responsibility and 
alignment of  clinical and operational goals and 
objectives (lack of integrated governance 
structures) 
2 3 6  
Lack of resources to accommodate both 
operational and clinical governance 
requirements 
3 4 12 2 
DRIVING FORCES     
Requirement to manage clinical risk following 
transfer of corporate wellness services to 
medical Screening Department  
5 3 15 1 
Near miss incidents highlighting potential safety 
risks 
5 2 10  
Non-conformance with EB best practice in 
service delivery 
3 3 9  
Concern of contracted service providers about 
lack of clinical oversight 
2 2 4  
Need to maintain overall service accreditation 
with Joint Commission International following 
transfer of corporate wellness services 
4 3 12 3 
Organisational risk management processes 3 2 6  
Scoring: IMPORTANCE (A): 5 Very Important to the Change 1 Of little importance 
EASE OF CHANGE (B): 1 Very Easy to Change      5 Very Difficult to Change 
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Appendix 3c, Part 3: Strategic approach  
STRATEGY FOR PRIORITY 1 
Design, peer review and implement evidence based quality and safety structures and 
processes. This requires: 
1. Clear vision of project drivers, goals and objectives 
2. Leverage ethical, clinical and medico-legal imperative 
3. Creation of sense of urgency and a driving coalition using  arrange of levers  
4. Find resources to initiate and plan project 
5. Create alignment of objectives to permit project implementation 
STRATEGY FOR PRIORITY 2 
Very difficult to address. Need to address all other restraining forces and strengthen driving 
forces in order to prioritise governance project and enable resource allocation: 
1. Communication of vision, approach and project plan 
2. Ensure proposed governance structures ‘fit for purpose’ 
3. Open discussion of impacts of new clinical structures and processes 
4. Negotiate alignment of objectives and ensure stakeholder engagement 
5. Revise governance policy and structures 
6. Highlight potential risks and shared nature of those risks 
7. Highlight potential benefits of increased quality and safety 
8. Articulate concerns of other stakeholders and leverage (e.g. organisational risk 
management) 
9. Clearly articulate evaluation and success criteria 
STRATEGY FOR PRIORITY 3 
1. Communicate risks  
2. Leverage JCI review dates to create urgency 
3. Highlight opportunities and potential benefits of combined accreditation 
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Appendix 3d: Power-Interest Matrix  
 
High 
power  
 Senior clinical 
management 
 Corporate business 
function (sales, 
strategy) 
 Regulatory bodies 
(JCI, HIQA, Medical 
Council, An Board 
Altranais) 
Context setters: 
Consult/empower 
 Clinical Management 
 Operations & Quality 
Management 
 Nursing managers   
 
Players: Collaborate 
Low 
power  
 Patients 
  
Crowd: Inform 
 Wellness project 
coordinators 
 Nursing team 
 Medical Team 
Subjects: Involve 
 
   Low impact/stake holding  High impact/stake holding  
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Appendix 4: Employee wellness service- risk assessment and gap analysis 
Status before 
change 
Deficit Risk  
Booking Minimal information given at booking 
No service resource planning 
No written process defining tasks and 
responsibilities  
No clinical-operational interaction 
Unrealistic expectations and client and 
patient dissatisfaction due to inefficient 
unprofessional service 
Inability to meet commitments/demand 
Inappropriate operational decisions 
made without clinical input resulting in 
adverse clinical outcome or increased 
clinical risk 
Medical and 
lifestyle 
questionnaire 
Questionnaire structure and content not 
ideal 
Problematic for nurses to manage 
Wasted consultation time 
Unprofessional impression and 
reduced competitiveness 
Focused nurse 
review of 
personal and 
family history 
Rationale and interpretation unclear Inaccurate or misleading 
information/advice provided 
Ineffective/unprofessional service 
Lifestyle 
evaluation 
No clear criteria for evaluation or advice Inaccurate or misleading 
information/advice provided 
Ineffective/unprofessional service 
Height, weight, 
BP 
Standards in need of revision Inaccurate or misleading 
information/advice provided 
Ineffective/unprofessional service 
Nurse delivered 
lifestyle 
consultation 
Professional but not evidence based Inaccurate or misleading 
information/advice provided 
Ineffective/unprofessional service 
Nurse fully 
responsible for 
care 
Medico-legal situation dubious 
Accountability and responsibility not clear 
Documentation of consultation sub-optimal 
Not consistent with standard practice 
Medico-legal risk to nurses, nursing 
organisation, wellness clinical 
management and organisation 
Incident and 
complaint 
reporting not 
integrated into 
quality 
management 
structure 
No integrated monitoring or analysis of 
incidents or complaints 
No structure/process for reporting to clinical 
or operational management of department 
No quality management structure/process 
Missed opportunities for intervention 
and prevention of risks 
Automated report No clinical review of accuracy Incorrect or misleading 
information/advice given 
Ineffective/unprofessional service 
No clinical 
oversight or follow 
up 
No mechanism to identify high risk 
individuals 
No mechanism for ensuring follow up with 
GP 
No mechanism to evaluate patient views 
Missed opportunity for intervention 
Serious preventable adverse event 
Ineffective service 
Missed diagnosis resulting in adverse 
clinical outcome 
Failure to meet ethical obligation to 
provide safe effective care 
Litigation and financial impact, 
reputational damage 
Professional impact 
Loss of accreditation 
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Appendix 5. Stakeholder Communication Plan 
Stakeholder 
group 
Issues Message  Approach Evaluation & 
feedback 
Nurse  
Team 
Test interpretation 
and health promotion 
best practice 
Management of 
urgent clinical issues 
Responsibility and 
governance 
Incident and 
complaint reporting 
 Near miss incidents 
 Clinical risk management 
 Quality and safety processes 
 Best practice in health 
promotion 
 Disseminate SOPs 
 Medico-legal context and 
responsibility 
 Evaluation and audit 
Workshops Survey 
questionnaire 
 
Indirect 
feedback via 
nursing 
managers 
Medical  
Team 
Management of 
urgent or complex 
clinical issues 
Clarity on roles and 
responsibilities 
 Drivers 
 Governance and 
responsibility 
 Clinical risk management 
 Clinical oversight processes: 
purpose and approach 
 Clinical governance best 
practice 
Clinical team 
meetings 
(monthly) 
and day to 
day 
discussion 
and feedback 
Survey 
questionnaire 
 
Informal 
discussion 
with doctors 
Nursing 
Managers 
Responsibility and 
accountability 
Ensure design fit for 
purpose and 
workable 
Maintain support for 
change 
Enable and support 
leadership of change 
project 
Communicate 
progress, coordinate 
implementation and 
address issues 
proactively 
Monitor resource 
implications 
 Triggers and drivers 
 Governance, responsibility 
and accountability 
requirements 
 Clinical governance best 
practice and quality 
assurance 
 Clinical risk management  
 Consultation on design of 
clinical oversight processes 
 Consultation regarding SOPs 
and governance policy 
 Consultation and 
collaborative approach to 
audit and evaluation design 
Regular 
meetings 
(every two 
months) and 
phone 
contact 
(weekly to 
two weekly) 
Regular face 
to face and 
phone 
contact and 
discussion 
Operational 
Management 
Generate urgency, 
engagement and 
progress 
Prioritise resources 
for change project 
Manage concern 
about cost and loss 
of flexibility 
 
 Drivers 
 Need to address current 
clinical-operational problems 
 Clinical risk management and 
‘near miss’ incidents 
 Clinical and clinical 
governance best practice 
 Operational weakness and 
missed opportunities 
 Strategic business fit  
 Accreditation risk and 
opportunity 
 Collaborative approach to 
design and implementation 
Twice 
monthly 
project 
meetings and 
informal 
discussion of 
issues 
Structured 
weekly 
meetings 
 
Informal 
discussions 
Senior 
Management 
Inform and consult 
regarding approach 
and progress 
 Confirm mandate 
 Confirm strategic alignment 
Monthly 
clinical 
governance 
report 
Phone or 
email as 
required 
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Appendix 6: Project objectives and plan 
 Objective What do I want to 
achieve 
What is the 
purpose 
What will 
success look 
like? 
How will I 
measure 
success 
1 Governance 
document 
Formal definition of 
clinical governance 
structures that apply to 
the service 
To ensure service 
accountability, 
and support 
sustainability 
An agreed signed 
off framework 
document which 
meets HSE and 
standards 
Sign-off by 
agreed date. 
Audit of 
governance 
document against 
relevant 
standards 
2 Establish 
stakeholder 
coalition and 
quality 
management 
structure 
 
Provide integrated 
clinical and operational 
management and 
quality management 
Ensure that safety 
and quality issues 
are reviewed and 
managed 
proactively 
Regular meetings 
attended by key 
stakeholders and 
regular review 
and auctioning of 
quality and safety 
issues 
Audit of meeting 
calendar and 
qualitative review 
of minutes 
3 Establish and 
implement clinical 
oversight 
structures and 
processes 
EB Standard operating 
procedures for clinical 
processes, effective 
clinical documentation, 
medical case review 
based on clinical risk 
assessment 
To support 
appropriate and 
safe delivery of 
clinical care and 
to  manage 
clinical risk 
Compliance with 
clinical oversight 
structures and 
processes. User 
acceptance 
User survey 
Clinical audit 
4 Clinical Audit Regular audit of 
clinical practice  
To ensure that 
service delivery is 
safe and effective 
Audit of clinical 
practice for 
nursing, medical 
and admin 
conducted and 
reported quarterly 
Timely reporting 
of adequate 
sample according 
to audit schedule 
Audit results 
5 Establish Incident 
& complaint 
reporting and 
management 
Process 
To ensure that safety 
and quality data is 
gathered and 
managed 
To ensure 
oversight and 
management of 
clinical and 
quality risks 
Daily reporting of I 
& C by screening 
project 
Audit of baseline 
and post-
implementation 
reporting 
6 Service user 
feedback 
 
To gather analyse and 
respond to service 
user views and needs 
To ensure service 
is meeting needs 
and wishes of 
service users 
Feedback 
obtained from 5% 
of service users 
each quarter 
Proportion of 
service users who 
responded 
 
7 Effective 
implementation 
and change 
management of 
project objectives 
Live, functioning 
sustainable clinical 
governance structures 
and processes 
Ensure 
accountability, 
safety and quality 
of service 
Live, functioning 
sustainable 
clinical 
governance 
structures and 
processes 
Survey 
Audit 
Progress 
evaluation 
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Appendix 7. Project Gantt Chart 
Stage  
& 
sub-stage 
Project  
task 
Start 
Date 
Plann
ed 
Finish 
Date 
Actual 
Finish 
Date 
M
ay 
 
Ju
n 
Ju
l 
 
A
u
g 
 
S
ep 
 
O
ct 
N
ov 
D
ec 
Ja
n 
Fe
b 
M
ar 
1  
Project 
Initiatio
n  
 
 
  
 
 
   
     
  
Review 
of 
corporat
e 
wellnes
s 
service 
and 
current 
status 
report 
May 
2014 
May 
2014 
20.05.
2014 √ 
 
 
   
     
  
Strategi
c 
analysis 
Jul.201
4 
Aug.20
14 
30.08.
2014 
 
 
 √ 
  
     
  
Strateg
y 
Meeting
, scope, 
objectiv
es and 
project 
approva
l 
Jul.201
4 
Sep.20
14 
30.09.
2014 
 
 
 
 √  
     
  
Ethical 
Approv
al 
Sep. 
2014 
Oct.20
14   
 
 
  √      
2.  
Project 
Plannin
g 
 
 
  
 
 
   
     
  
Establis
h 
project 
team 
Aug.20
14 
Sep.20
14 01.09.
2014 
 
 
 
√   
     
  
Establis
h 
regular 
stakeho
lder 
meeting
s 
Sep.20
14 
Sep.20
14 
30.09.
2014 
 
 
 
 √  
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Stage  
& 
sub-stage 
Project  
task 
Start 
Date 
Plann
ed 
Finish 
Date 
Actual 
Finish 
Date 
M
ay 
 
Ju
n 
Ju
l 
 
A
u
g 
 
S
ep 
 
O
ct 
N
ov 
D
ec 
Ja
n 
Fe
b 
M
ar 
 2.1 
Design 
and 
Approv
al of 
Overall 
Clinical 
Govern
ance 
Docum
ent 
 
 
  
 
 
   
     
  
Literatur
e 
review 
of 
clinical 
governa
nce 
Jul.201
4 
Nov.20
14 
30.11.
2014 
 
 
 
  √ 
     
  
Docum
ent 
design 
and 
review 
Aug.20
14 
Nov.20
14 
30.11.
2014 
 
 
 
   
√     
  
Stakeho
lder 
approva
l of 
governa
nce 
docume
nt 
Oct.20
14 
Dec.20
14 
24.12.
2014 
 
 
 
   
 √    
 2.2 
Design 
Clinical 
Govern
ance 
Structur
es and 
Process
es  
 
 
  
 
 
   
     
  HbA1c 
Jul.201
4 
Aug.20
14 
30.08.
2014 
 
 
 √        
  
Define 
clinical 
oversig
ht 
structur
es and 
process
es as 
SOP 
Jul.201
4 
Aug.20
14 
30.08.
2014 
 
 
 
√   
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Stage  
& 
sub-stage 
Project  
task 
Start 
Date 
Plann
ed 
Finish 
Date 
Actual 
Finish 
Date 
M
ay 
 
Ju
n 
Ju
l 
 
A
u
g 
 
S
ep 
 
O
ct 
N
ov 
D
ec 
Ja
n 
Fe
b 
M
ar 
  
Map 
service 
and 
define 
non-
clinical 
SOPs 
and 
write 
operatio
nal 
SOP 
Jul.201
4 
Aug.20
14 
28.02.
2015 
 
 
 
   
    X 
  
Design 
process 
for 
gatherin
g 
quality 
and 
safety 
data 
(inciden
t, 
complai
nts, 
service 
user 
respons
es) 
Jul.201
4 
Aug.20
14 
30.08.
2014 
 
 
 
√   
     
  
Design 
quality 
manage
ment 
process 
Jul.201
4 
Sep.20
14 
31.01.
2015 
 
 
 
   
   √  
  
Define 
audit 
goals 
and 
manage
ment 
process 
and 
design 
audit 
tools 
Jul.201
4 
Aug.20
14 
30.08.
2014 
 
 
 
√   
     
 2.3 
Stakeho
lder 
review 
and 
agreem
ent 
Sep.20
14 
Sep.20
14 
30.09.
2014 
 
 
 
 √  
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Stage  
& 
sub-stage 
Project  
task 
Start 
Date 
Plann
ed 
Finish 
Date 
Actual 
Finish 
Date 
M
ay 
 
Ju
n 
Ju
l 
 
A
u
g 
 
S
ep 
 
O
ct 
N
ov 
D
ec 
Ja
n 
Fe
b 
M
ar 
 2.4 
Dissemi
nation 
and 
Training 
Oct.20
14 
Nov.20
14 30.11.
2014 
 
 
 
   
√     
3.  
Project 
Implem
entatio
n 
 
 
  
 
 
   
     
  
Implem
ent 
service 
user 
feedbac
k 
gatherin
g 
Nov.20
14 
Nov.20
14 
30.11.
2014 
 
 
 
   
√     
  
Conduc
t initial 
audits 
Nov.20
14 
Nov.20
14 
30.11.
2014 
 
 
 
   
√     
  
Implem
ent 
quality 
improve
ment 
process
es 
Nov.20
14 
Nov.20
14 
31.01.
2015 
 
 
 
   
   √  
  
Conduc
t 
second 
audits 
Feb.20
15 
Feb.20
15 31.03.
2015 
 
 
 
   
    X 
4.  
Project 
Evaluat
ion 
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Stage  
& 
sub-stage 
Project  
task 
Start 
Date 
Plann
ed 
Finish 
Date 
Actual 
Finish 
Date 
M
ay 
 
Ju
n 
Ju
l 
 
A
u
g 
 
S
ep 
 
O
ct 
N
ov 
D
ec 
Ja
n 
Fe
b 
M
ar 
  
Evaluat
e 
implem
entation 
of 
clinical 
oversig
ht 
system 
and 
quality 
data 
gatherin
g 
(service 
data, 
survey 
and 
audit) 
Nov.20
14 
Feb.20
15 
28.02.
2015 
 
 
 
   
   √  
  
Evaluat
e 
change 
manage
ment 
process 
Nov.20
14 
Feb.20
15 
28.02.
2015 
 
 
 
   
   √  
  
Evaluat
e 
quality 
manage
ment 
structur
es and 
process
es 
Jan.20
15 
Feb.20
15 
28.02.
2015 
 
 
 
   
   √  
  
Evaluat
e 
service 
outcom
es 
Nov.20
14 
Feb.20
15 
28.02.
2015 
 
 
 
   
   √  
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Appendix 8: Project Risk Log 
Risk  Risk to project success 
Impact 
(1-5) 
Likeliho
od (1-5) 
 
Risk 
Rating 
Action to proactively control 
risk 
1 
Project will not be 
prioritized by operational 
management 
3 3 
9 Create a sense of urgency, 
collaborate, good 
communication, strategic 
alignment. 
2 
Resources will not be 
prioritised to design and 
implement the change 
4 2 
8 
Establish project priority 
3 
Resources will not be 
prioritised to sustain the 
change 
4 3 
12 Merge system with existing 
processes 
Leverage accreditation 
Leverage strategic alignment 
4 
Cost of the change will 
be prohibitive 
5 1 
5 Initial outline of costs conducted 
Design appropriate to scale of 
service and fit for purpose 
5 
The project will not be 
completed on time 
2 4 
8 Planning, regular review, 
maintain urgency, develop good 
working relationships 
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Appendix 9: Audit of Governance policy document against HSE clinical 
governance development checklist (HSE 2012) 
 Governance  
 
Met? Governance document 
1 Has documented and communicated to all staff that the 
CEO/general manager/ service lead has overall 
accountability, responsibility and authority for quality, 
patient safety and clinical outcomes. 
 
Met  Roles and 
responsibilities and 
organisational chart. 
Governance document 
disseminated. 
2 Provides an organisational chart setting out the 
accountability arrangements and reporting relationships 
for all staff within the organisation. 
 
Met Organisational chart 
3 Clearly sets out and integrates the roles of administrative 
and clinical staff in management/leadership posts, as 
they relate to service delivery. 
Met Description of roles and 
responsibilities 
4 Clearly identifies and agrees the lines of responsibility, 
accountability and authority of the following personnel: ■ 
CEO/GM/equivalent ■ Executive Clinical Director; ■ 
Clinical Director(s); ■ Director of Nursing/ Midwifery; ■ 
Executive /Senior Management Team; ■ 
Service/professional leads. 
Met Organisational chart and 
Roles and 
Responsibilities 
5 Has established a joint meeting of senior hospital, 
primary care and community representatives to review 
and address how services are working together. 
N/A Not applicable 
6 Has established a multidisciplinary committee to review 
and address quality and safety issues and incidents e.g. 
clinical governance and/or quality, safety and risk 
management (QRSM) committee(s). 
Met Quality management 
policy and structures 
7 Provides clear reporting lines and escalation policies 
between committees on quality safety and risk 
management (QRSM) issues (where multiple 
committees exist). 
Met Reporting and 
escalation policy 
Incident and complaint 
management policy 
8 Ensures an annual report is produced on: ■ service 
quality improvements completed; ■ evidence of 
performance indicators showing improvement; ■ learning 
from incidents, complaints and risk management; ■ 
patient experience / service users views; and ■ 
practice/clinical audits undertaken. 
 
Not 
met 
Reporting and 
escalation policy 
9 Makes quality and safety a criterion against which 
financial or headcount resource decisions are made. 
 
Partly 
met 
Implicit in governance 
structure and 
responsibilities. Not 
explicit. 
KPIs 
 
10 Has a suite of key performance/quality indicators in line 
with national priorities and standards. 
 
Met KPI policy 
11 Sets agenda items on management team/board 
meetings to monitor and review the indicators at defined 
intervals. 
Met Reporting and 
escalation policy and 
KPI policy 
12 Benchmarks the health service provider’s performance 
locally, nationally and/or internationally. 
 
N/A  
13 Publicly reports the outcomes of the key performance / 
quality indicators. 
 
NA  
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Learning and Sharing Information  
 
14 Ensures that information systems are in place to support 
quality safety and risk management in identifying, 
monitoring and responding to risk and important aspects 
of care. 
 
Met Incident reporting and 
management Policy 
Risk evaluation and 
management policy 
15 Has an effective flow of information on safety and quality 
matters to and from the board / executive/senior 
management team. 
 
Met Reporting and 
escalation policy 
16 Has a procedure for responding to alerts from external 
bodies (for example from HIQA, IMB) that is documented 
and communicated to all staff. 
Met Incident reporting and 
management policy 
17 Has a process for systematic monitoring of, and learning 
from, safety incidents at local, regional and national 
levels. 
 
Met Incident management 
policy 
Patient and Public Community Involvement 
 
18 Regularly seeks feedback on patient experience and 
integrates this into quality and safety improvement 
activities. 
Met User Satisfaction 
Feedback policy 
19 Reviews the response time and procedure for complaints 
from patients and the public. 
 
Met Complaints 
management policy 
20 Supports an open consistent approach to communicating 
with patients when things go wrong. 
Not 
Met 
Not explicit in 
governance document 
Risk Management and Patient Safety  
 
21 Has risk management processes in line with the HSE 
Code of Governance, national standards and policy e.g. 
■ risk identification recording and reporting   ■ risk 
mitigation / risk reduction ■ incident / adverse event 
reporting ■ incident investigation ■openness and 
accountability. 
Met Risk Management policy 
22 Supports any member of the team who wishes to raise 
concerns about the quality and safety of the service. 
Met Incident reporting and 
management policy 
23 Where externally provided services are commissioned, 
the practice of corporate and clinical governance, are 
clearly implemented by the provider (in the service or 
grant aid agreement) 
 
Met Accreditation policy 
Clinical Effectiveness and Audit 
 
24 Ensures that services comply with relevant legislation 
and regulatory requirements. 
 
  
256 Has implemented and agreed national standards, 
guidelines and other policies, procedures, protocols for 
quality safe patient care (in line with the National Clinical 
Effectiveness Committee and other relevant national 
committees). 
Met Quality standards 
Guidelines policy 
26 Has a structured programme of clinical audit that is 
monitored for appropriateness and effectiveness on an 
annual basis (including participation in national audits). 
 
Met  Clinical Audit Policy 
Staffing and Staff Management 
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27 Has robust recruitment and selection procedures 
including professional credentialing and Garda vetting 
(where appropriate). 
 
Met Accreditation policy 
28 Has a requirement that all new staff complete induction 
for their role and maintain their competence. 
Met  Accreditation policy 
29 Clearly identifies and communicates the arrangements 
for evaluating individual performance including managing 
under performance. 
 
Met Accreditation policy 
30 Clearly identifies and communicates the arrangements 
for evaluating team performance including managing 
under performance. 
 
Met Accreditation policy 
31 Engages with staff around how clinical governance can 
influence their everyday behaviour and surveys the 
patient safety culture across the organisation.  
 
Met Accreditation policy 
Information Management 
 
32 Has a system to uniquely identify each patient. 
 
Met  Data protection and 
information 
management policy 
33 Provides information systems, whether electronic or 
paper-based, which are integrated and interface with 
other systems to support high quality safe healthcare. 
 
Not 
Met 
Information governance 
policy 
34 Ensures all information including personal information, is 
handled securely, efficiently, effectively and in-line with 
legislation 
Met Data protection and 
information 
management policy 
Capacity and Capability 
 
35 Has developed and implemented plans for ongoing 
training, development and education on quality, safety, 
and risk management 
Met Accreditation policy 
36 Provides human, infrastructural and financial resources 
to implement effective quality, safety and risk 
management systems etc. 
 
Partly 
met 
Implied but not explicit in 
governance document. 
 Results of audit of clinical governance policy document against HSE clinical 
governance development checklist (HSE 2012) 
Number of standards 36 
Not applicable 3 
Applicable 33 (100%) 
Met 25 (76%) 
Partly Met 2 (6%) 
Not met 6 (18%) 
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Appendix 10. Audit Tools 
 
Person Responsible: Nurse manager 
Objective/aim: To monitor adherence to processes and policies relating to 
on-site screening and to identify opportunities for 
improvement. 
Frequency of audit: 3 monthly 
Reference: 
Source  / standard / 
evidence base 
SOP X and Y 
Type: 
 
Process      √           Outcome  
Retrospective    √    Concurrent  
Sample/population: Population – all people undergoing screening during audit 
period. Sample – sample size adjusted to total population to 
ensure sampling at the 95 % confidence interval.  
Exclusion/inclusion criteria: None 
Sample selection method: 2 records selected from each nurse screening project  
Data analysis plan: 1. Completeness of documentation (consent, pt details, 
questionnaire, results, referral sheet, other referrals, 
doctor calls). 
2. Completeness of comments (Advice given and 
documented regarding all relevant lifestyle issues) 
3. Urgent issues managed according to SOP (BP, 
possible DM, unwell attendees, severe stress, A&E 
referrals) 
4. Alert criteria (all who should have been referred 
were) 
Target result: Baseline audit: initial target 80% adherence for 1. and 2. and 
100% adherence for 3. and 4. 
Audit tool file reference: Nurse Process Audit Checklist 
Audit design approved by: Quality Committee 
Dissemination Nurse Workshops 
Stakeholder review meetings 
Quality committee 
 
 
 
 
 
 
 
 
 
 
 
Audit Title: Audit of Nurse Process  
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Audit Title: Audit Doctor Process  
 
Person Responsible: Lead Clinician 
Objective/aim: To monitor adherence to processes and policies relating to 
on-site screening and to identify opportunities for 
improvement. 
To monitor the current threshold for medical review. 
Frequency of audit: 3 monthly 
Reference: 
Standard  
SOPx and SOPy 
Type: 
 
Process      √       Outcome  
Retrospective   √ Concurrent  
Sample/population: Eligible Population- all patients referred for medical review, 
all patients who had venous blood tests, all patients where 
doctor was phoned, all patients referred to A&E. 
Sample – 100% of patients referred for medical review. 
Exclusion/inclusion criteria: Only patients referred for review or where the doctor was 
phoned, or who were referred to A&E will be included in the 
audit. 
Sample selection method: 100% of patients referred for medical review through alert 
criteria, phone advice or A&E referral. 
Data analysis plan: 1. Medical review patient reports and advice 
appropriate. 
2. % of screenings with venous blood tests reviewed 
and patient reports and advice appropriate. 
3. % of A&E referrals appropriate, clearly documented 
and referred to doctor for follow up. 
4. % phone contacts documented  
5. % of referrals conforming to SOP 
Target result: 100% compliance for 1 – 5 above  
Audit tool file reference: Doctor process audit checklist 
Audit design approved by: Quality Committee 
Dissemination Medical Team Meetings 
Quality committee 
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Appendix 11. Service user survey 
ON SITE SCREENING 
 
Open survey in workplaces 
Firstly, did you recently take part in on-site Health Screening service? 
 Yes  
 No  
 
How did you hear about the  Health Screening service? 
Tick any/all that apply 
 Email  
 Information stand  
 Representative  
 HR department in my workplace  
 Other, please let us know: ____________ 
 
To what extent would you agree with the following statements about the  Screening service on a scale of 1-10: 
Where 1 = Strongly disagree and 10 = Strongly agree 
 1  2  3  4  5  6  7  8  9  10  
The Screening service was well promoted to the 
employees in my organisation            
The appointment booking method/system was easy to 
use            
I had a clear understanding of what was involved in 
the Screening service in advance            
The Screening team were professional            
I am satisfied with the quality of service provided by 
the  Screening team            
 I would recommend the  Screening service to fellow 
colleagues and friends in the future  
          
 
To what extent did the Screening service increase your knowledge of lifestyle changes and  help you manage 
your own health? 
 A lot  
 A little  
 Not at all  
 
Have you acted on the advice given from the Screening service? 
 Yes, fully  
 Yes, partially  
 Not at all  
 
Please let us know of any comments you may have about (or improvements that we could make to) the 
Screening Service: 
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Appendix 12: Survey response rate and summary of stakeholder responses 
Group Number % response 
All 22/43 51% 
Nursing 9/18 50% 
Medical 8/16 50% 
Clinical & Operational 
Management and Administration 
5/9 55% 
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Appendix 12. RCSI Ethics Committee Approval Letter. 
 
